The Texas Medical Center Library

DigitalCommons@TMC
UT School of Public Health Dissertations (Open
Access)

School of Public Health

Spring 5-2020

SHARED DECISION MAKING IN THE CARE OF POST-ACUTE
PSYCHIATRIC INDIVIDUALS WITH SERIOUS MENTAL ILLNESS
NATALIE J. MAPLES
UTHealth School of Public Health

Follow this and additional works at: https://digitalcommons.library.tmc.edu/uthsph_dissertsopen
Part of the Community Psychology Commons, Health Psychology Commons, and the Public Health
Commons

Recommended Citation
MAPLES, NATALIE J., "SHARED DECISION MAKING IN THE CARE OF POST-ACUTE PSYCHIATRIC
INDIVIDUALS WITH SERIOUS MENTAL ILLNESS" (2020). UT School of Public Health Dissertations (Open
Access). 126.
https://digitalcommons.library.tmc.edu/uthsph_dissertsopen/126

This is brought to you for free and open access by the
School of Public Health at DigitalCommons@TMC. It has
been accepted for inclusion in UT School of Public Health
Dissertations (Open Access) by an authorized
administrator of DigitalCommons@TMC. For more
information, please contact
digitalcommons@library.tmc.edu.

Copyright
by
Natalie J. Maples, BS, MA, DrPH
2020

DEDICATION
This dissertation is dedicated to Eric Gilbert, Stefanie Martinez and Kelly Hamilton. I cannot
thank you enough for your never-ending encouragement and support.

SHARED DECISION MAKING IN THE CARE OF POST-ACUTE PSYCHIATRIC
INDIVIDUALS WITH SERIOUS MENTAL ILLNESS

by
NATALIE J. MAPLES
BA, Texas A&M University, 1997
MA, St. Mary’s University, 1999

Presented to the Faculty of The University of Texas
School of Public Health
in Partial Fulfillment
of the Requirements
for the Degree of

DOCTOR OF PUBLIC HEALTH

THE UNIVERISTY OF TEXAS
SCHOOL OF PUBLIC HEALTH
Houston, Texas
May, 2020

ACKNOWLEDGEMENTS
A special thanks to my advisor and dissertation chair Dr. Melissa Valerio-Shewmaker for
the continuous support, patience, and guidance throughout my DrPH studies. I also want to
thank committee members Dr. Eric Jones and Dr. Robert Morgan for their encouragement,
insightful comments, and hard questions. I want to give immense thanks to my external
reviewer, Dr. Erin Espinosa, for dedicating her time to reviewing my dissertation and providing
thoughtful critique. Lastly, I want to acknowledge and thank my boss, mentor and close friend
for over two decades, Dr. Dawn Velligan, for her valuable review and expert feedback.

SHARED DECISION MAKING IN THE CARE OF POST-ACUTE PSYCHIATRIC
INDIVIDUALS WITH SERIOUS MENTAL ILLNESS

Natalie J. Maples, BA, MA, DrPH
The University of Texas
School of Public Health, 2020

Dissertation Chair: Melissa A. Valerio, PhD

Severe mental illness in adults refers to a group of mental health conditions including
schizophrenia and schizoaffective, bipolar and major depressive disorders. These conditions are
often characterized by recurring symptoms, multiple hospitalizations, and significant disability.
The public health concern with these conditions is amplified because many individuals with
severe mental illness fail to engage in outpatient treatment. Methods to support greater rates of
participation in outpatient treatment are needed. Encouraging participation in medical decisionmaking is viewed as one method to optimize patient empowerment, increase engagement in care
and decrease the negative outcomes that often characterize this population. Shared Decision
Making (SDM) is a collaborative and structured approach to patient-provider communication
viewed as a negotiation between mutual experts with the goal of balancing empirical information
with patient values and preferences.

This was a cross-sectional mixed methods study examining SDM in a sample of
individuals with severe mental illness who have recently been discharged from emergency rooms
and inpatient psychiatric facilities. Extant data on decision-making preferences and a variety of

clinical, demographic and communication variables were analyzed on 258 individuals with
severe mental illness during a baseline visit at a transitional care clinic serving individuals
immediately after hospital discharge. The association between clinical, demographic and
communication characteristics and patients’ self-reported decision-making preference (active,
collaborative, or passive) were examined using chi square and one-way analyses of covariance.
In addition, we conducted semi-structured qualitative interviews with 15 individuals with serious
mental illness a variety of clinical providers (n = 9).

Results from the quantitative analyses indicated that race/ethnicity was significantly
associated with the SDM preference group, with African American individuals desiring more
active participation in decision making compared to their Hispanic counterparts. Other
characteristics were not significantly associated with the patient’s baseline decision-making
preferences in this context. Qualitative data were analyzed using latent thematic analysis and six
themes were identified including: 1) Differences in the Use of SDM, 2) Consideration of Past
Experiences, 3) Decisional Power Preferences, 4) Use of SDM in Psychiatry Versus Other Areas
of Medicine, 5) Dignity and Disengagement, and 6) External Forces Impacting SDM. These
findings indicate race/ethnicity may be an important factor when using a SDM approach.
Implications for clinical practice and research using a SDM approach within this treatment
setting are further discussed.
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BACKGROUND
Engagement in mental health services following hospitalization is of critical importance
for improving the lives of individuals with severe mental illness and reducing long term
disability. In this manuscript, we describe the personal and societal costs of severe mental
illness, models of care for this population, the importance of shared decision making in the
treatment-engagement process, and the barriers and facilitators of shared decision making. Next,
we propose a research project designed to better understand patient preferences for different
types of decision making during encounters with prescribers and elucidate the process of shared
decision making and treatment from the patient and prescriber-staff perspectives.

Severe mental illness in adults refers to a group of mental health disorders often defined
by length of illness duration and the disability it produces. These illnesses include disorders that
produce psychotic symptoms, such as schizophrenia and schizoaffective disorder, and severe
forms of affective disorders, such as major depression and bipolar disorder (SAMHSA, 2016). It
is estimated that 4.6% percent of the adult US population is diagnosed with one of these
conditions at any given time (NIMH, 2016). Serious mental illness is one of the leading causes of
disability worldwide according to the global burden of disease disability weights (Kessler et al,
2009; WHO, 2006). The course of this group of disorders is often characterized by recurring
exacerbations and multiple hospitalizations (Moller, 1995). Additionally, recent literature reports
people with serious mental illness die 10-20 years earlier than do those not suffering from this
group of diseases (University of Oxford, 2014; Lund University, 2013); much of the excess
mortality being due to physical illness. The comorbidity of medical illness in this population is
well documented, including particularly elevated rates of diabetes mellitus (2-3 fold), metabolic
1

syndrome (1.5-2 fold), cardiovascular disease (2-3 fold) and viral diseases (5-11 fold), when
compared to the general population (DeHert et al, 2011; Sokol et al, 2004).

The per patient lifetime burden of serious mental illness is estimated at $1.85 million
(Seabury et al, 2019). Services with the highest costs include hospitalization and emergency
department visits. In an extensive review of psychiatric admissions to 418 U.S. communitybased hospitals, it was determined that the three most common diagnoses included depression
(27.8%), schizophrenia/schizoaffective disorder (19.5%) and bipolar disorder (19.4%; Stensland
et al, 2012). These diagnoses are included in the broader category of serious mental illness.
Typical psychiatric hospitalizations for the severely mentally ill last only a few days (x̅ = 4.4 –
11.1; Stensland et al, 2012), leaving many individuals still experiencing severe psychiatric
symptoms at the time of discharge. The recurring hospitalization and emergency care utilization
as part of ongoing serious mental illness management coupled with an over-burdened outpatient
mental health service care system (Mead, 2002) result in as many as one-half of these individuals
failing to connect to sustained outpatient care (Boyer, 1997). This places patients at greater risk
of numerous negative outcomes, including repeated emergency department visits and inpatient
hospitalizations, homelessness, violence against others and suicide (Dixon et al, 2009; Fisher et
al, 2008). According to Pasic and colleagues (2005), high utilization of hospital and emergency
services points to a quality of care and access problems in outpatient care that must be addressed.
To this effect, it has been suggested that these negative outcomes may decrease within the mental
health population if patients have more involvement in psychiatric decision making (Kemp,
2011). Correspondingly, engagement in outpatient services may be enhanced with a higher level
of patient empowerment within the patient-physician dyad (McCallister, 2016).
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Poor long-term engagement in outpatient treatment contributes to psychiatric rehospitalization and more frequent emergency department visits (Pasic et al, 2005). There is
substantial evidence that psychiatry patients miss approximately 20% of ongoing treatment
appointments, and nearly half of patients who miss an appointment drop out of care, leading to
premature discontinuation rates in psychosocial treatment, as high as 82% (McMurran, 2010;
Mitchell, 2007; Wierzbicki, 1993). Specific to hospitalization data, Prince (2006) reports that
patients who are not engaged in care (i.e. medication appointments) within three months of
hospital or emergency department discharge, experience significantly higher re-hospitalization
rates than patients who do participate in aftercare treatment (OR=6.9, p<0.001). Moreover,
medication non-adherence rates often exceed 50% in psychiatric samples (Velligan et al, 2006),
with ethnic minorities and younger adults consistently less likely to take medications as
prescribed (Rossom et al, 2016; Garcia et al, 2016; Lee et al, 2008).

The importance of treatment engagement and continuity of care between inpatient or
emergency room facilities and outpatient services to prevent this revolving door phenomenon has
been continually stressed (Mental Health America, 2010). Even minimal contact with aftercare
treatment is associated with lower recidivism rates (Silva, 2009); conversely, delays seeking
outpatient care following psychiatric hospitalization are linked to poorer outcomes (Prince 2006;
Weiden, 2004). Based on these studies, the months immediately post-discharge appear critically
important for implementing strategies to improve engagement in outpatient treatment. However,
research on the best way to increase post-acute psychiatric patients’ long-term engagement with
mental health services is mixed and provides no clear direction for treatment improvement.
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There is some suggestion from recent published literature on the general population that
long-term engagement into outpatient treatment may be assisted by empowerment of the patient
in decisions about their care within the patient-provider dyad (McCallister, 2016). Within the
seriously mentally ill population specifically, various intervention approaches have been used to
increase follow-through adherence to outpatient treatment (Roberts, 2011), but most methods do
not emphasize the importance of patients participating in their own treatment decisions. Shared
Decision making (SDM) is an exception. SDM is a structured approach to patient-provider
communication in medicine that frames the interaction as a negotiation between mutual experts
and stresses the balanced use of empirical information and patient preference in decision making
(Charles, 1997).

There are few published large-scale studies of SDM in persons with serious mental
illness. This lack of information results in a knowledge gap in several areas. Two of these gaps
are addressed in this proposal.

1) There is little research examining how patient preferences for involvement in the
process of treatment decisions with a prescriber relate to clinical and demographic
characteristics. Furthermore, there is no published literature addressing how patients’ clinical and
demographic characteristics relate to their perceptions of the decision-making encounter. In
addition, it is unclear how these clinical and demographic characteristics relate to discrepancies
in how patients and prescribers view the encounter.

4

2) There is no published information regarding the feasibility of using an SDM approach
in a post-acute psychiatric clinic. The perspectives of both patients receiving SDM and
prescribers/staff functioning within this context have not been researched. These questions may
be best addressed using in-depth interviews with those participating in the provider–patient
interactions.

The specific aims of this study address these gaps and are listed below.

Specific Aims
Aim #1: Characterize the demographic and clinical differences between groups of patients
who desire differing levels of involvement in psychiatric decision making.
Use pre-existing data on 258 individuals with serious mental illness to characterize patient
preferences for types of decision making using the Control Preference Scale into three groups
(Active/Collaborative/Passive). Examine group differences on patient demographic and clinical
variables, how patients view the initial encounter with prescribers, and the extent to which their
view of the encounter differs from that of the prescriber.

Aim #2: Identify the factors influencing the use of a shared decision-making model in post
psychiatric crisis care delivery.
Assess individual experiences with the shared decision-making model, barriers and facilitators of
the approach, and the feasibility of using the model for care delivery from the perspective of
prescribers, clinic administrators, therapists nursing staff and patients. This is accomplished via
one-on-one interviews with fifteen patients, four prescribers, two therapists, one nurse and two
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clinic administrators.

Literature Review
Post Hospital Engagement in Care
There are several models of post-hospitalization care presented in the literature. Dixon
and colleagues (2009) use a brief intervention implemented for individuals with serious mental
illness at time of hospital discharge focusing on assessing barriers to treatment and facilitating
engagement in community-based services. This three month intervention increased show rates to
outpatient medication appointments, although no effect was found on rehospitalization. In an
older sample of 59 psychiatric inpatients, Kopelowicz (1998) found that patients with
schizophrenia who participated in a re-entry program for one month post-discharge were
significantly more likely to attend their first aftercare appointment. While one study associated
the use of day treatment for individuals with schizophrenia with a significant reduction in future
admissions (Kopelowicz, 1998), a review article of four randomized trials concluded there is
insufficient evidence to deem such intense treatment effective within this population (Shek,
2010). Additionally, in a study on the use of medication management coordinators providing
continuity of care procedures between inpatient and outpatient care for persons diagnosed with
severe mental illness, survival curve analyses reveal those in active treatment attended outpatient
appointments sooner in comparison to the control group, but no difference was found in time to
next psychiatric hospitalization (Maples, 2012). These studies suggest there is no clearly
effective strategy leading to improved engagement in outpatient treatment after hospitalization or
to improved outcomes, indicating other options need to be investigated. Next, several models are
explored to provide a foundation for potential intervention strategies.
6

Chronic Care Models and Framework
Drawing from the public health literature, we examined multiple models describing the
management and delivery of chronic care. Models selected were based on the following
parameters: 1) The relationship of the model to chronic relapsing conditions involving high
service use and high cost, 2) The inclusion in the model of optimization of patient self-direction
and outcomes and 3) The inclusion of a component of training and competency for the
professional staff providing care. We excluded models (ecological, social-ecological and
exposome) not addressing breaking the repeated cycle of rehospitalization often experienced in
this group of illnesses and those without a focus on enhancing empowerment of the individual in
treatment. The three models discussed in this proposal include, Wagner’s Chronic Care Model,
the Institute for Healthcare Improvement Triple Aim Framework and Mulley’s Conceptual
Framework for Shared Decision making. These models have primarily been discussed with
respect to physical illness but remain relevant to severe and persistent mental health disorders as
explained below.

Wagner’s Chronic Care Model
In a review article by Wagner et al (1996), the authors stress the need for integrated,
patient-centered care for chronic illness. Wagner’s model (Figure 1) emphasizes that patients be
actively involved in their own care, and also emphasizes practice redesign, ongoing education for
providers, and meaningful use of information systems (Wagner et al, 1999). This transformative
model of health care delivery addresses how to overcome the following deficiencies:
practitioners being rushed, a lack of care coordination, the lack of active follow-up, and patients
being inadequately trained to manage their illness (Wagner et al, 1996). As seen in Figure 1,
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changes in both the community and in the health system itself can lead to a more informed and
activated patient, in addition to a more prepared and proactive practice team--with improved
outcomes being the primary goal. As seen in the model, changes within the community and the
health system that promote access, communication across agencies and patient education must
occur together to reach the overall goal of improved patient outcomes. While Wagner’s model
pertains to the health industry in general, these same principles may apply to the treatment
settings of individuals with serious mental illness. Given the information previously presented on
comorbidity between serious mental illness and physical health diagnoses—including the
increased morbidity and mortality rates—the application for more integrated care, the redesign of
practice, and meaningful use of information systems is necessitated in treating this chronically ill
population.
Figure 1. Wagner’s Chronic Care Model

Source: Wagner EH, 1998
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Institute for Healthcare Improvement Triple Aim Framework
The Institute for Healthcare Improvement’s (IHI) Triple Aim is a framework describing
an approach to optimizing health system performance. The Triple Aim consists of: 1) Improving
the patient experience of care (including quality and satisfaction), 2) Improving the health
of populations; and 3) Reducing the per capita cost of health care (Berwick et al, 2008). These
three aims can be seen in Figure 2, a simple yet notable plea for designing healthcare systems. A
shared decision-making approach within the seriously mentally ill population is relevant to all
three of the Aims outlined in the model. Shared decision making has been found to improve the
patient’s experience of care by encouraging providers to present more treatment options and
involving patients to a greater extent in decsions. This can have an important impact on early
engagement in treatment and promoting satisfaction with care. This may help to increase
appointment adherence which is often a problem in providing services for this population.
Expediting indivdiuals into care immedately following an acute psychiatric exacerbation and
engaging them in the decision making process is likely to improve health outcomes and reduce
healthcare costs. Most importantly, this framework calls for efforts to improve care and close
the treatment gap for individuals with serious mental illness across a variety of settings; an
unified behavioral health strategy which includes the patient in helping direct their own care is
essential to achieve the Triple Aim.

9

Figure 2. The Institute of Healthcare Improvement’s Triple Aim

Source: Institute for Healthcare Improvement, 2020

Mulley’s Conceptual Framework for Shared Decision Making
The concept of shared decision making is previously and briefly mentioned in this
dissertation proposal. The model presented here (Figure 3) is the original published by Mulley
(1990) with a target audience of primary medicine. As described by Mulley (1990), SDM is a
systems approach to enable continuous improvement in clinical decision making. The model
focuses on two key participants, the patient and provider. There is a fundamental social nature in
the decision-making task that cannot be completed by the doctor or patient alone, but rather
requires productive interactions (and communication) between them. The model focuses on three
types of events. First, decisions – the selection of treatment based on patients’ well-informed
preferences for health outcomes. Second, clinical practice – where the treatment is implemented.
Third, health outcomes – the expected result of treatments. The model includes two major
feedback loops to indicate how learning occurs in the system. The top loop feeds knowledge
about the likelihood of outcomes to providers to promote evidence-based medicine. The bottom
10

loop feeds knowledge about the patient’s subjective assessment of experiences with those
outcomes back to the point of decision making to support more informed choices.

In this shared decision-making model, prescribers are primarily responsible for knowing
and appropriately applying the knowledge base. Patients are primarily responsible for
contributing well-informed subjective assessments of possible health states relevant to decisions
and for reporting outcomes and experiences with and assessment of these health states. The
responsibility on key participants is high, but also at the center of success in such a model. The
complexity and responsibilities required raise questions as to appropriateness for application
within a post-acute psychiatric population. However, the three concepts postulated – decisions,
clinical practice and health outcomes, certainly remain relevant whether in a mental or physical
health population. Additionally, current clinical practice guidelines advocate for all clinicians,
regardless of public health sector, to involve clients in decision making processes and allow for
client preferences, along with the evidence, to guide decisions where possible. This model
provides the opportunity to optimize patient self-direction in mental health treatment and
outcomes.

11

Figure 3. Mulley’s Conceptual Framework for Shared Decision Making

Source: Sepucha and Mulley, 2009

In conclusion, the frameworks presented in this literature review are all consistent with
the mission of The Center for Medicare and Medicaid Innovation for improved care delivery
systems, as part of the Affordable Care Act (Shrank, 2013; Barr et al, 2010). However, they
simultaneously raise questions on applicability and achievability of several synchronous complex
processes needed to achieve better outcomes for patients. Next, a body of literature is presented
on shared decision making, the principal subject for the remainder of this proposal.

Shared Decision Making
Research suggests that long term engagement into outpatient treatment may be assisted
by empowerment of the patient in decisions about their care within the patient-provider dyad.
Patients who feel they are playing an active role in their treatment typically have better
12

engagement and outcomes than patients who experience themselves as passive recipients of care
(Greenfield, 1988; Seeman 1983; Stewart 2001). Unfortunately, across diagnoses and conditions,
patients more typically engage with providers in a passive manner (Britten, 2000; Towle, 2003),
and lack of engagement is related to poor adherence with prescribed regimens. Poor adherence
has severe consequences for individuals immediately following hospitalization or crisis care,
often leading to recidivism and decreased quality of life (Velligan, 2009).

Although various intervention approaches have been used to increase follow-through
adherence to outpatient treatment in serious mental illness (Roberts, 2011), most methods do not
emphasize the importance of patients participating in their own treatment decisions. Shared
Decision making is an exception. SDM is a structured approach to communication in medicine
that frames the interaction as a negotiation between mutual experts (patient and provider) and
stresses the balanced use of empirical information and patient preference in decision making
(Charles, 1997). Within the physical medicine field, there is substantial evidence that SDM
increases patient participation in and adherence to treatment and may decrease adverse events
and unnecessary procedures (Dowell, 2007; Stewart, 1995; Wennberg, 2007). SDM also appears
to increase patients’ knowledge about and realistic understanding of the targeted illness
(Auerbach, 2001). SDM is compatible with evidence-based medicine in its emphasis on the use
of empirical information to make treatment decisions (Guyatt, 2001), and with the serious mental
illness consumer recovery movement in its emphasis on patient-centered care (Drake, 2010).

SDM is well operationalized, with specific components and clinician competencies detailed in
the literature (Campbell, 2007; Elwyn, 2005). SDM coaching is an approach where clinical staff,
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following standard SDM concepts, help empower patients with the goal to enhance patient
communication skills, knowledge and options for communication with their prescribers.
Coaching visits occur prior to the medication appointment and are one-on-one meetings that
address patients’ treatment and diagnosis questions, informational needs, goals, medication
concerns and strategies for communication. In light of the research on chronic care presented
above, SDM may be effective with chronic conditions, such as psychiatric illness, because the
focus of SDM is to help the individual be a more educated and involved consumer of health
services, with the inherent opportunity to direct more of their own care.

Barriers to SDM Implementation with Serious Mental Illness
Despite the apparent promise of SDM, there is a low level of adoption and
implementation of this practice within the delivery of mental health care, relative to other areas
of medicine. The delivery of mental health services remains for the most part a providerdominated decision-making climate, reflecting poor uptake of this practice (Curtis, 2010;
Shumway, 2003). Possible reasons for the insufficient adoption of SDM within this population
are further explained. Table 1 summarizes barriers to SDM implementation and dissemination in
the seriously mentally ill population. These factors are further illuminated below.

Table 1. Summary of Potential Barriers to SDM Implementation in Seriously Mentally Ill
Population
Summary of Potential Barriers to SDM Implementation in Seriously Mentally Ill
Population
Prescriber/Systemic Factors

• Overworked physicians
• Insufficient provider training/knowledge in SDM
• Deficient medical information systems
14

Patient Factors

Illness/Symptom Factors

•
•
•
•

Physician time constraints
Lack of applicability to population
Inappropriate clinical situation (i.e. crisis clinic)
Mixed opinions on amount of involvement in
decision process
• Patient perceptions of clinician failures at using
SDM
• Inability of patient to accurately articulate
information (Possible need for decision support
aids)
• SDM participation requires higher cognitive load
• Persons with serious mental illness may suffer
from cognitive impairment or judgment
difficulties
• Depression makes decision making more difficult
• Mania may lower the threshold for risk tolerance
• Schizophrenia may lead to passive acceptance
(i.e. apathy) or rigid non-compliance (i.e.
paranoid delusion)

Prescriber/Systemic Factors
It is difficult to separate prescriber and systemic barriers to SDM implementation as
they appear to be integrally intertwined. Efforts to increase patient involvement in decisions
about their care face barriers such as overworked physicians, insufficient provider training,
deficient medical information systems, physician time constraints, a deemed lack of applicability
due to patient characteristics and inappropriate clinical situations (Legare, 2008; Towle, 2006).
From the standpoint of efficiency, when SDM is used in prescriber-patient interactions, visits are
perceived by prescribers to take more time than does a standard psychiatry appointment (Burton,
2010)—and doctors cite this as one factor that limits their use of SDM (Legare, 2008; Towle,
2006). While the need for SDM content varies in each prescriber-patient appointment (i.e. patient
experiencing side effects or is decompensating versus no complaints), all prescriber-patient
interactions should include some component of SDM when following the model correctly. As
15

physicians use SDM only about 10% of the time (Braddock, 1997; Elwyn, 2003), efficiency
appears to be an important perceived obstacle to the feasibility and dissemination of SDM.

Despite a desire to know more about their diagnosis, treatment options and side effects
(Beisecker, 1990; Degner, 1997), psychiatric patients report that prescribers often do not provide
sufficient information or explain it in an understandable manner (Garfield, 2004). A large
interview-based study on perceived obstacles and needs in providing SDM in public mental
health corroborated this patient perspective, concluding that mental health providers require
additional training in effective patient communication—above and beyond the kind of training
they receive for other chronic and acute physical health conditions (Mahone, 2011).

Patient Factors
There are mixed reviews on patients’ desires for more information on care options and
amount of involvement in the medical decision-making process (Legare, 2008, Legare, 2006).
During a baseline office interview in the general (non-psychiatric) population, one study found
25% of patients want an active role where they are primarily responsible for the decision, 53%
want a collaborative role and 21% want a passive role that gives the prescriber more power in the
decision making process. Additionally, Mahone (2011) suggests that in addition to the need for
more provider training, patients’ perceptions of clinician failures at using SDM may be due in
part to illness-related information processing deficits in the patient, recommending increased
training for patients in articulating their expert information during treatment sessions. To aid in
information exchange and knowledge building, reviews of SDM in mental health have called for
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the use of decision support aids and other scaffolding techniques to support patient preferences in
decisions about their care (Deegan, 2006).

Illness/Symptom Factors
In addition to prescriber, systemic and patient factors, symptoms that typically
accompany serious mental illness cause concerns about patients’ abilities to fully participate in
SDM. SDM requires a certain amount of cognitive capacity to understand treatment options and
weigh their pros and cons against one’s own preferences. Many individuals with serious mental
illness suffer from cognitive impairments that may hinder their ability to complete this complex
cognitive processing. Further, some psychiatric conditions specifically affect judgment and
decision making, calling into question the decisional capacity of psychiatric patients to make
informed decisions about their care (Appelbaum, 2006; Hamann, 2003). Additionally, depression
makes decision making more difficult; mania may lower the threshold for risk tolerance;
schizophrenia may alternately lead to passive acceptance or to rigid adherence to one idea
(Moritz, 2006), such as a paranoid fear regarding medication.

Strengths of SDM Implementation in Serious Mental Illness
While there are obvious barriers to SDM implementation, SDM has many strengths and
evidence supports the use such an approach for those with serious mental illness. Table 2
summarizes these strengths and the information is expanded on below.
Table 2. Summary of Strengths to SDM Implementation in Seriously Mentally Ill
Population
Summary of Strengths to SDM Implementation in Seriously Mentally Ill Population
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Prescriber/Systemic Factors

Patient Factors

Illness/Symptom Factors

• Support through the New Freedom Commission
on Mental Health and other government policy
reports
• High incidence of patient non-adherence,
partially due to dissatisfaction
• For rational/purposeful medication noncompliance, SDM may constitute a reasonable
approach to remaining engaged in care while
continually re-evaluating the potential role of
medication
• SDM represents a non-threatening approach for
prescribers to clarify motivation
• Reports reveal nearly 90% of patients want
information on diagnosis, treatment options and
side effects
• Specific demographic factors may contribute to
patients' preference to play a more active role in
decision making
• Patient experience and knowledge of illness, type
of decision needed and attitude towards
involvement affect desire to be active in decisions
and care
• Evidence that persons with serious mental illness
frequently make competent and prudent treatment
decisions
• Medication taking is often part of a deliberate
self-care plan
• Persons with serious mental illness express a
strong desire to be informed about illness and
treatment options

Systemic Factors
Research on SDM in psychiatry has received support through the New Freedom
Commission on Mental Health (New Freedom Commission, 2003), and other recent government
policy reports (Institute in Medicine, 2001; IoM, 2005). SDM may be of particular benefit in
serious mental illness because of the high incidence of patient non-adherence with treatment due
to factors including dissatisfaction with side effects from antipsychotic and mood stabilizing
medications, poor insight into illness and functional and motivational impairments. Competent
18

adults with serious mental illness sometimes choose to decline medication and suffer symptoms
rather than endure side effects, or to limit their use to periods of symptom exacerbation
(Donovan, 1992; Angermeyer, 2001). For these patients, SDM may constitute a reasonable
approach to remaining engaged with care providers and take advantage of treatment options such
as case management and/or alternative medications and psychotherapy, while continually reevaluating the potential role of antipsychotic medication. For patients with poor insight or
functional impairment, SDM represents a non-threatening approach to clarifying motivations and
options for improving quality of life.

Patient Factors
In surveys, nearly 90% of patients in the general population want information on their
diagnosis, treatment options and side effects (Beisecker, 1990; Degner, 1997). However, it is
unknown whether this preference translates to those with severe mental illness, especially to
those experiencing an acute psychiatric exacerbation. In a 2006 review of patients’ preferences
for involvement in decision making, Say et al (2006) report demographic variables, including
being younger, better educated and female were consistently found to be associated with a
preference for a more active role in decision making. The authors add that patient experience of
illness, the type of decision they need to make, the amount of knowledge they have acquired
about their illness and their attitude towards involvement, also affect desire to be involved in
care.

Illness/Symptom Factors
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Contradicting the risks related to symptomatology, there is evidence that adults with
serious mental illness frequently make competent and prudent treatment decisions (Grisso, 1995;
MacDonald et al, 2017). For example, a study of medication decision making in schizophrenia
found that nearly 87% of patients prescribed injectable (depot) antipsychotics chose to continue
(Bunn, 1997). In a large study of patient self-care in serious mental illness, when patients made
firm decisions about whether or not to take medication they typically did so as part of a
deliberate self-care plan. Also, despite frequent behavioral passivity, patients with serious mental
illness express a strong desire to be informed about their illness and treatment options, and to be
active participants in their treatment decisions (Adams, 2007; Arora, 2000; De las Cuevas,
2001).

Feasibility
While few large-scale studies exist on the use of SDM within the seriously mentally ill
population, at least two studies demonstrate promise. A trial that provided a medication decision
aid and coaching for communication with doctors to inpatients diagnosed with schizophrenia
(N=107) found that the intervention was feasible and well tolerated by patients and was
associated with a trend toward decreased rehospitalization (Deegan, 2006). A second inpatient
trial (Hamman, 2011) randomized patients with schizophrenia or schizoaffective disorder to
either an SDM intervention (N=32) or cognitive training (N=29). The SDM intervention
comprised five sessions addressing motivation for decision making participation and role-play
practice to improve communication skill. SDM was found to be feasible and was associated with
increased desire for participation in treatment decisions relative to cognitive training, a finding
that remained at six-month follow-up.
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In summary, there is a body of evidence in the published literature on shared decision
making. Despite promising data on the use of SDM, the uptake of this practice is poor within
services provided to the seriously mentally ill population. A better understanding of the factors
related to shared decision-making styles in different patients and issues related to its
implementation may be critical to maximizing individual patient outcomes. Currently, there is
insufficient evidence on how much involvement severely ill psychiatric patients desire to have in
their patient-provider interactions regarding psychiatric decisions. While previous studies have
found factors such as age and gender to impact the desired level of involvement in care, it is
unclear if these results translate to the population of individuals with severe mental illness.
Moreover, there is no evidence to date on how factors such as the level of psychiatric
symptomatology, level of insight and ethnicity are related to patient’s desire to participate in
treatment. Furthermore, little is known about the opinions of those engaging in SDM within a
post-acute psychiatric clinic and how these beliefs by patients or providers may hinder or
facilitate the uptake of SDM within this population. This lack of information results in a gap in
the current knowledge base on the viability of SDM usage within this population and a postacute psychiatric clinic.
Public Health Significance
Specific to mental health, The President’s New Freedom Commission (PNFC) on Mental
Health identified patient-directed care as one method of service delivery that could improve the
quality and outcomes of mental health (PNFC, 2003). The Commission called for nothing short
of fundamental transformation of the mental health care delivery system in the United States,
from one dictated by bureaucratic and financial incentives to one driven by consumer and family
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needs that focuses on building resilience and facilitating recovery. In its October 29, 2002,
Interim Report to the President, the Commission declared that the mental health service delivery
system must be robust and responsive to consumers' needs because its failings may lead to
"unnecessary and costly disability, homelessness, school failure and incarceration." The report
points out that mental illnesses and emotional disturbances are treatable, and that recovery
should be the expectation. Successfully transforming the mental health service delivery system to
promote recovery hinges on treatments that are consumer driven. Finally, the report underscores
the importance of giving consumers real and meaningful choices about treatment options.

Based on the body of research presented throughout, methods of increasing patient
engagement that incorporate treatments driven by the consumer are of national public health
significance. A myriad of poor patient outcomes coupled with high financial costs for those
diagnosed with serious mental illness promote research on the barriers, facilitators and feasibility
of novel interventions in this population, including patient-level factors surrounding treatment
involvement. Research supports the promise of SDM for enhancing engagement in post-acute
treatment despite multiple levels of barriers. SDM interventions appear to be feasible yet more
research is needed to empirically determine provider and patient opinions and feasibility in
adopting these practices into a post-acute psychiatric crisis setting. Additionally, research on how
patient preferences in decision making during the provider-patient dyad affect satisfaction with
communication and care delivery will advance the practice of SDM in the seriously mentally ill
population.
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Objectives
The overall objectives of this study are to investigate the association between the
patient’s level of desire to participate in treatment decisions and demographic/clinical factors
including, ethnicity, and degree of symptomatology and insight. The study also examines how
initial preference for decision-making style relates to how the initial visit with the prescriber is
perceived by both the patient and the prescriber. In addition, qualitative data on the use of a
shared decision-making approach during post-acute psychiatric medication appointments is
obtained. This study explores multi-level staff and patient opinions on the barriers, facilitators
and feasibility of using shared decision making within a clinic setting, information not currently
found in the published literature. In this effort, the study addresses the gap in research regarding
the use of shared decision making within a seriously mentally ill population receiving post-acute
psychiatric care.

Conceptual Model
Following the review of the literature, a conceptual model (Figure 4) was created to
inform the proposed research that incorporates prior conditions and new research to complete
Aims 1 and 2. Within the model, assumed components of SDM include prescriber training, SDM
coaching, equality within the patient-prescriber dyad and patient-centered care. Other prior
conditions include the knowledge base presented in the literature review on both barriers and
strengths to SDM implementation. In Figure 4, the lower portion of this study’s conceptual
model focuses on new research including all data gathered from qualitative interviews and
existing quantitative data. The conceptual model also includes possible outcomes gleaned from
the data analysis. The model additionally incorporates constructs from the chronic care models
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previously presented and elements of the SDM literature review. Details specific to Aim 1 and
Aim 2 are further explained.

For Aim 1, previous literature reports data on the extent to which patients desire
involvement in their own care and how this preference is related to age and gender. However,
studies in the general population have been inconsistent with respect to these relationships.
Additionally, it is unclear how these relationships will translate to an acutely mentally ill
population. Moreover, there is little information on patient-prescriber agreement on
communication during SDM medication visits and how this may relate to patient preferences or
demographic characteristics. These are included in this study’s conceptual model (Figure 4) and
will be addressed in the quantitative portion of this study.

Regarding Aim 2, all three conceptual frameworks emphasize the need for patients to be
actively involved in their own care. Wagner (1996) and Mulley (1990) specifically advocate for
patient and provider education on treatment options. As part of clinic procedures, patients are
provided SDM coaching, consisting of help to empower patients with the goal of enhancing
patient communication skills, knowledge and options for communication with their prescribers.
Clinic staff was trained in SDM practices including respect for the patient, equality within the
dyad and patient-centeredness. These key communication skill-building components also align
with the IHI and Mulley’s (1990) recommendations to improve patient experiences, increase the
exchange of information, and help empower the patient to be more involved in their own
treatment decisions. Through the qualitative interviews (Aim 2), the concepts endorsed by
previous medical frameworks will be investigated within a post-acute psychiatric population to
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help improve the current knowledge gap within this population. Time and resources associated
with the delivery of SDM will also be explored in the qualitative interview portion of this study
addressing the IHI construct of cost of healthcare and a possible barrier to SDM implementation.

Figure 4. Conceptual Model of using Shared Decision making in Post-Acute Psychiatric
Clinic

METHODS
Study Design
This was a cross-sectional mixed methods study examining shared decision making in a
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sample of individuals with severe mental illness who have recently been discharged from
emergency rooms and inpatient psychiatric facilities. The specific aims were as follows:

Aim #1: Characterize the demographic and clinical differences between groups of patients
who desire differing levels of involvement in psychiatric decision making.

Aim #2: Identify the factors influencing the use of a shared decision-making model in post
psychiatric crisis care delivery.

Study Site
The study site was a Transitional Care Clinic funded by an 1115 Medicaid Waiver, area
hospitals and charitable organizations. Participants in the study were drawn from a convenience
sample who participated in a research study examining outcomes in engagement-focused care
versus usual care between the years of 2014 and 2016 (Patient-Centered Outcomes Research
Institute (PCORI); Contract number: IH-1304-6506) as well as a de novo sample of individuals
actively receiving treatment at The Transitional Care Clinic. The clinic provides a wide range of
services including medication management, evidence-based psychotherapy and case
management. All clinic prescribers were trained in utilization of SDM within a patientprescriber dyad and general SDM practices for prior to data collection for the original parent
study.

Sample
Aim 1 for the current was based on quantitative data collected at baseline as part of the
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original parent study, but not analyzed to examine the questions proposed here. Aim 2 required
the de novo collection and examination of qualitative interview data from current patient and
clinic staff populations at the Transitional Care Clinic. These interviews were not part of the
original trial but added by the PI (Maples) to enhance understanding of the main trial results. All
aims for this dissertation are fully different than those of the original research study.

The quantitative patient sample included a convenience sample of 258 individuals with
severe mental illness who attended post-acute psychiatric hospitalization appointments at The
Transitional Care Clinic during the original study. Severe mental illness was defined as DSM5
primary diagnosis of schizophrenia, schizoaffective disorder, bipolar disorder, depression,
unspecified psychosis and unspecified mood disorder were included. Due to the nature of this
being the first clinic visit, some providers used an unspecified diagnostic category until more
information regarding history and symptoms were clearer. Severe mental illness, rather than
clinical diagnosis, defined the study population as research demonstrates that diagnosis is often
unreliable and unstable over time and is a poor predictor of clinical outcomes (Cuthbert et al.
2013). By virtue of their acceptance into this clinic, participants are over 18 years of age, have
been recently discharged from an inpatient psychiatric unit or triaged from an emergency room,
and received a diagnosis of severe mental illness. and a diagnosis of severe mental illness as
defined above.

The patient sample for key informant interviews (Aim 2) was recruited at The
Transitional Care Clinic. Trained clinic staff approached patients during routine medication visits
at the clinic to obtain initial verbal consent allowing the PI contact them regarding the study.
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The PI followed up to provide a full description of the study protocol and procedures. If the
individual agreed to participate, they were invited to partake in an interview at a time and date
convenient to them. All interviews were completed at the clinic.

Qualitative interviews were also conducted with clinic staff. Additional key informants
interviewed included clinic administrators, therapists, nursing staff and prescribers. Prescribers
included a mixture of three psychiatrists and one nurse practitioner. These clinic staff were
approached via email by the PI and asked of their interest to participate in the study. If interested,
the PI proceeded with a review of the study and scheduling the qualitative interview. Study
participation was voluntary and did not impact the person’s employment status or annual
evaluation. Interviewed staff were not supervised or under any authority of the PI.

For patient interviews, sampling was deemed to reach saturation at 15 patients, or the
point to which we had achieved informational redundancy. That is, no new information or
themes were emerging from the data (Patton, 2002). Simple random sampling was used to
identify a patient subset. There were approximately 300 eligible participants weekly with a
diagnosis of severe mental illness seeking treatment at the transitional care clinic. A random digit
was generated and clinic staff approached every fifth person based on the generated number.
Staff continued to approach incoming patients until the desired number of 15 consented and
interviewed subjects was obtained.

Staff interviews were conducted with four prescribers (three psychiatrists, and one nurse
practitioner), two therapists, one nurse and two clinic administrators following a semi-structured
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qualitative interview. All pertinent clinic staff were approached to participate in the interview.
All approached staff agreed to the interview. The proposed staff sample size was small, due
entirely to the number of employed staff members involved in patient treatment, but saturation
was still reached with no new themes emerging after the ninth interview.

Quantitative Assessments
Demographic Data: Patient level demographic data available for the quantitative
analyses included age (at time of baseline medication appointment), ethnicity, gender and
diagnosis at time of first clinic appointment.
In the quantitative portion of this study, we examined patient demographic and clinical
characteristics at baseline in relation to the level of control an individual reported wanting to
assume when decisions were being made about medical treatment. We additionally examined
patient and prescriber quantitative ratings of prescribers’ in-session communication gathered
after each baseline medication visit. Specific quantitative measures are described below.

Control Preferences Scale (CPS). Patient preference for participation in SDM is an
important potential moderator because not all patients wanted to play an active role in their
treatment decisions. This domain is measured with the Control Preferences Scale (CPS; Degner
et al, 1997; Appendices A & B). The control preferences construct is defined as "the degree of
control an individual wants to assume when decisions are being made about medical treatment"
(Degner et al, 1997). This scale presents patients with five cards that each present a statement
describing a different role in decision making. Statements include: (A) I prefer to make decisions
about which treatment I receive; (B) I prefer to make the final decision about my treatment after
29

seriously considering my doctor’s opinion; (C) I prefer that my doctor and I share responsibility
about which treatment is best for me; (D) I prefer that my doctor make the final decision about
which treatment will be used but seriously consider my opinion; (E) I prefer to leave all
decisions regarding my treatment to my doctor. Cards were presented to the patient in pairs in a
pre-specified order (B, D, C, A, and E) until the five statements are rank ordered. This
assessment took approximately five minutes to complete. Sorting produced six different possible
categorizations of how involved patients wanted to be in decisions. These included: 1) ActiveActive, 2) Active-Collaborative, 3) Collaborative-Active 4) Collaborative-Passive 5) PassiveCollaborative and 6) Passive-Passive (Appendix A). Note that all control preferences data had
already been collected as part of the original study. For the purposes of the current study, we
collapsed the six classifications into three: Active (Category 1-2), Collaborative (Categories 3-4),
and Passive (Categories 5-6).

The CPS is the most frequently used measure of patients’ preference for different levels
of control in medical treatment decisions. The psychometric properties of the CPS have been
established across a variety of medical and behavioral health conditions and across languages
and cultures. The measure is reliable across time and observer, has moderate internal
consistency; and good convergent validity (Degner et al, 1997; De las Cuevas & Peñate, 2016;
Singh et al, 2010, Garfield et al, 2007).

Matched Pair Instrument (MPI). Patient and prescriber ratings of prescribers’ insession communication was obtained using the Matched Pair Instrument (MPI; Campbell et al,
2007; Appendices C & D), a dyadic instrument comprised of 19 statements that assess the
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content and process of a prescriber’s communication skills from each patient’s perspective. Each
skill on the MPI is rated on a 5-point scale with higher scores indicating stronger agreement with
the statement. The prescriber and patient completed a version immediately following the
encounter. A total score for each participant is derived. In addition, a difference score between
provider and patient ratings was calculated. The absolute value of this score reflected the
average distance between patients and providers in their perceptions of communication during
the session. Campbell et al (2007) demonstrate good internal consistency and reliability of this
scale over time and a systematic review of 20 measures of physician-patient communication
evaluated the psychometric properties of the MPI as similar to other instruments assessing this
construct. However, the review recommended further psychometric testing for all of the
instruments reviewed. In part, the MPI was chosen over other possibilities due to the evaluation
of the advisory board for the transitional care clinic. They recommended the MPI as being
relatively simple for patients to complete and having high acceptability.

Expanded Brief Psychiatric Rating Scale (BPRS). The Expanded Brief Psychiatric
Rating Scale (BPRS) was used to characterize psychiatric symptoms amongst patients the
(Ventura et al, 1993; Appendix E). This scale is a 24-item interview-based measure that captures
a range of psychiatric symptoms rated on 7-point Likert scales, with higher scores indicating
more severe symptomatology. This scale is summed to yield a total score and four factor scores
(agitation-mania, depression-anxiety, positive symptoms, and negative symptoms; Appendix F).
Positive symptoms refer to an excess or distortion of normal function. Examples include
hallucinations and delusions. Negative symptoms refer to a decrease or absence of normal
function. Examples include lack of/reduced emotion, loss of interest and apathy. The reliability
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of BPRS over time and across raters has been established over decades of use (Ventura et al,
1993). The instrument has been validated across a variety of languages and cultures (Shafer et al,
2017). In addition, the measure is sensitive to change in treatment and correlates with global
measures of psychopathology such as the Clinical Global Impression (Leucht et al., 2006).

Scale to Assess Unawareness of Mental Disorders (SUMD). The abridged version of
the Scale to Assess Unawareness of Mental Disorders (SUMD; Amador et al, 1994; Appendix
G) was used to measure patient insight into having a psychiatric illness. This semi-structured
open interview evaluates three items including global insight, insight into illness and insight into
symptoms on a 5-point Likert scale with higher scores indicating lower insight. The SUMD is
widely used in clinical trials and epidemiological studies and the abbreviated version has
demonstrated good internal consistency and external validity (Michel et al, 2013).

Qualitative Assessments
We conducted semi structured open-ended interviews with both clinic staff and current
patients attending The Transitional Care Clinic.

Patient and Staff interviews
Interviews for patient participants were conducted by the principal investigator (Maples)
and lasted approximately 30-40 minutes. They were conducted in person in the clinic and patient
participants were paid for their time. Prior to the interviews, the PI explained the purpose of the
interview and the importance of open sharing of opinions.
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The interview was developed by the PI in collaboration with experts in the Department of
Psychiatry, and the stakeholder advisory board of the Transitional Care Clinic to address specific
themes in the theoretical model. It follows a semi-structured format which began with general
open-ended questions regarding the patient’s experiences with mental health care and proceeded
to more specifically address shared decision making and its impact upon care. Topics addressed
included the patients’ experiences with satisfaction with prescriber interaction and impact of the
SDM process on medication visit outcomes. Both the staff and patient versions of the interview
guide can be found in Appendices H and I, respectively. Interviews were audio recorded and all
audio tapes were transcribed by research staff. Audio files were permanently deleted after
transcription.

Clinic staff participants were interviewed using a semi-structured interview schedule
developed by the PI in conjunction with experienced researchers in the Department and the
stakeholder advisory board of the transitional care clinic. Important domains were identified and
agreed upon, summarized by the PI, and collated into a semi-structured interview guide. The
interview guide consists of questions about staff experiences using shared decision making as a
practice within the transitional care clinic, including feasibility and utility. The interviews were
carried out by the PI and lasted approximately 30 minutes. Interviews were conducted in person
at the staff member’s office.

Avoidance of bias
Selection bias during qualitative interviews is a possibility. Patients who agree to
participate in the qualitative interviews may feel more emotional, either good or bad, about the
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treatment at the crisis clinic. Information bias, a bias arising from measurement error, is also a
consideration. This is possible with self-report data resulting in a differing quality, or amount of
accuracy, in information between the three comparison groups. Information bias is also possible
from the staff sample, again due to self-report data affecting the accuracy of information
obtained. Another potential confounding variable needing consideration is provider’s level of
shared decision making during actual practice. While all providers have been equally trained in
the SDM process, providers use different methods based on their own medical training, personal
beliefs or years’ experience. An additional confounder includes the severity of acute
exacerbation within the patient population. While all patients attending the Transitional Care
Clinic have recently been discharged or averted from a psychiatric hospitalization, there are
differing levels of symptom severity (i.e. suicidal ideation versus suicide attempt) which may
affect the desired level of involvement in the patient-provider dyad and the perception of the
encounter.

Data Management
All extant quantitative data was entered into a relational database meeting HIPAA
requirements, using software that provides for double entry and numerous internal validity
checks. All data are stored in HIPAA compliant password protected computer databases by
subject numbers. No identifying information such as social security numbers, names or
birthdates are included in the database. Data is maintained and backed up daily to prevent data
loss and ensure full data retrieval for analyses. Security is maintained through a network
manager. Quantitative data was analyzed using the Statistical Analysis Software (SAS version
9.3; SAS; Cary Institute).
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Data Analysis
Quantitative Data Analysis
For analysis of quantitative data, we combined categories from the Control Preferences
Scale into three larger groups reflecting their preferred SDM style; 1) Active, 2) Collaborative
and 3) Passive. The primarily Active Group includes those patients who fell into either the
Active-Active or Active-Collaborative categories. These patients tend to prefer to make most of
the decisions with very little or no input from the doctor. The Collaborative Group includes
patients who fell into either the Collaborative-Active or Collaborative-Passive categories. These
patients prefer a very collaborative interaction where decisions are equally based on doctor
patient input. The primarily Passive Group includes those patients who fell into either the
Passive-Collaborative or Passive-Passive categories. These patients prefer interaction where their
doctor has the majority of weight in decision making.

Chi square analyses were used to examine group differences (Active/ Collaborative/
Passive) by gender and ethnicity to determine whether there is an increased likelihood that one
gender or specific ethnic groups have a preference for specific styles of medical decision
making. One-way analyses of variance were used to examine CPS group differences
(Active/Collaborative/Passive) on continuous measures including age, BPRS total score, BPRS
factor scores, insight into having a psychiatric illness (SUMD total score), MPI difference scores
and MPI patient rating. All tests were two-tailed. Demographic and clinical data are used to
determine if differences exist between groups of patients who desire differing levels of
involvement in psychiatric decision making. The measures specific to SDM allow us to examine
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how patients view the initial encounter with prescribers, and the extent to which their view of the
encounter differs from that of the prescriber.

Sample size and Power Analysis
A power analysis was conducted on categorical and continues variables in a group of
258, split into three unequal groups - Active, Collaborative and Passive, representing
approximately 26%, 53% and 21% of the population, respectively. The power analysis on fixed
effect in the analysis of variance and covariance, with three groups, a total subject size of 258,
and effect size of 0.2, the power of the F test on means at α=0.05 criterion is 0.82. This indicates
we have sufficient power to detect differences across the three groups created from the control
preferences scale (Cohen, 1988).

Qualitative Analysis
To analyze interview data, we use an iterative process that consists of three steps:
“noticing, collecting, and thinking” (Seidel, 1998). Interviews were audio recorded and
transcribed by research staff and were coded by the PI and another faculty member in the same
University and Department. Latent thematic analysis was used to analyze this exploratory data
(Braun & Clarke, 2006) and NVivo 12 software was used to organize the data (NVivo 12, QSR
International Pty Ltd, 2018). Each participating group (patient and provider) was analyzed
independently and then the group data were combined. Using inductive category development,
the codes from all transcripts were thematically clustered to serve as the basis for higher level
categories, of which there were 12. Inductive categorization allowed for coding the data without
trying to fit it into a pre-existing coding frame, or the researcher’s analytic preconceptions
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(Braun & Clarke, 2006). This flexible method is used to identify patterns of meaning within data
among participants and is not allied to any particular framework. We looked for themes
especially relevant to differences in experiences of and preferences for SDM (e.g. desired
balance of power); satisfaction with provider visits, including length of visits; how previous
experiences affect current desire for and use of SDM; and consequences of not using an SDM
approach. All codes were then grouped into these categories by the two researchers. Following
thematic latent analysis (Braun & Clarke, 2006), the 12 semantic categories were further
analyzed at the latent level to identify higher order themes, of which there were six. Any areas of
disagreement were resolved by discussion until consensus was reached.

Sample size for Qualitative Analysis
Sample size for patient interviews is projected to reach saturation at n=15. Sample size
for the staff interviews are set by number of current staff members.

Strengths and Limitations of the Study
This study contributes to the limited published literature on shared decision making
within the mental health field. Additionally, this is the first evaluation of the perceptions and
preferences of individuals with serious mental illness and their providers regarding SDM in a
clinic serving a population immediately following a psychiatric crisis or hospitalization.
Strengths in this study include the sample size of the quantitative data, psychometric properties
and variety of the quantitative assessments, in depth interview guides and the use of two coders
for qualitative data.
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While there are many strengths to this study, limitations are also present. In the
quantitative analyses, the data is retrospective and we are unable to add to the current sample.
Additionally, we are limited to the baseline visit without any follow up data for these
participants. The cross-sectional nature of this study does not allow for examination of difference
in SDM styles over time. A relatively smaller percentage of African American study participants
make it difficult to generalize from these results. In addition, all qualitative interviews are
performed in one clinic. Interviewing patients and providers in different areas may extend the
variability of responses.

Human Subjects and Safety Considerations
The safety of participants was monitored using procedures developed in the Division of
Community Recovery, Research and Training over decades. Detailed training in good clinical
practice and informed consent procedures helps to ensure appropriate protection of human
subjects. The principal investigator has been trained in clinical research interview techniques,
including methods to obtain data in a non-threatening manner. All subjects, including staff, are
told they are free to withdraw from participation in the interview at any time. The principal
investigator has twenty years’ experience working with individuals with severe mental illness,
including expertise in semi-structured interviews with this population, and has trained more than
50 staff in maximizing participant confidentiality and comfort. Prior to participating in the
PCORI study all patients went through an informed consent process which included an
assessment of the ability to give consent. Potential participants needed to answer specific
questions to determine whether they understood the study and what would be expected of them.
If they were unable to correctly answer these questions, some additional training was provided.
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If potential participants were still unable to answer questions, they were not allowed to sign
informed consent for the study.

Sources of Research Material. We examined data collected as part of the original PCORI study
and we collected information from subjects via in person interviews. All data collected is used
for the purpose of research.

Recruitment
For Aim 1, no recruitment occurred as preexisting data was be used. For Aim 2, 15
patients were interviewed. Trained clinic staff familiar with the patients requested initial patient
participant consent during in-person medication visits to The Transitional Care Clinic. For
further description of the study, including full consenting procedures, the principal investigator
followed up with those giving verbal consent. Individuals were invited to participate in an
interview at a time and date convenient to them. Nine clinic staff members were interviewed.
Provider participants were recruited via email from the PI requesting participation in the study.
Staff were informed of the purpose of the interview and accepting staff were interviewed in their
office at a time and date convenient to them.

Informed Consent
The research study was deemed exempt by UT Health San Antonio’s Institutional
Review Board (IRB) due to no collection of identifying information. The consent form would
have been the only piece of identifying information able to be tied back to either patient or staff
participants. As such and per the request of the IRB, the PI created a checklist of pertinent
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information of the study and this checklist was presented to the participants. Each participant
was given a checklist to take with them including the contact information of the PI should they
have questions after the interview. The 24 participants were asked to participate in an interview
about shared decision making. They all provided verbal consent to audio record the interview
and were made aware that transcripts of the audio tapes were made. Participants were informed
that no identifying information was retained and only an identification number would appear on
the transcript. All participants were informed that to further protect confidentiality; audio tapes
were to be erased following transcription. All participants were informed that only researchers
had access to the tapes and transcripts; no others involved with the Transitional Care Clinic or
UT Health San Antonio are aware of their answers, and their responses cannot affect their status
in at the Transitional Care Clinic or employment at UT Health San Antonio.

The existing quantitative data used in this dissertation was gathered from a preexisting
PCORI-funded research study. All subjects signed an informed consent form and the study was
approved by UT Health San Antonio IRB.

Confidentiality
Participant information will not be shared with anyone outside the research team.
Participants were not identified by name during the taping. A study ID is attached to each
participant’s transcript. All participant information from the original trial is contained in a
HIPPA compliant database with no PHI attached.

Compensation
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Patients participating in qualitative interviews were paid $30 for their time. Clinic staff
participating in qualitative interviews were not be reimbursed for their time. Interviews were
conducted during normal business hours and is intended to further the knowledge of the research
within this topic area for future publication and possible grant applications, dependent on
findings.

Potential Risks and Procedures to Minimize Risks
Risks of study procedures can include distress and heightened sensitivity that can occur
as part of participation in clinical interviews; and potential breaches in confidentiality. While the
possibility of such events is low given the procedures taken to minimize risk, the PI monitored
these situations. The potential for these risks was reduced by adherence to guidelines of good
clinical practice and formal supervision and training of personnel. If subjects became upset when
discussing their treatment, the PI was available to consult with them.

Information is not be disseminated without the patient’s written consent. Case records are
kept in a secure location in password-protected files. Access to these files is restricted only to our
research staff. Computer based information is identified by numbers and codes only. No names
appear in the data files. The database is password protected. The risks to patients in this study are
balanced by the importance of the information that will be obtained on treatments to improve
mental health outcomes. We have used similar assessment procedures for more than 2 decades.
The PI and research staff are experienced in conducting trials with individuals with serious
mental illness.
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The analysis proposed is presented in two formatted journal articles. Each will follow author
instructions from a peer-reviewed journal and will be presented as a full paper. These will be
followed by a chapter that will summarize the two papers and the implications for practice.
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JOURNAL ARTICLE I

Patient Preferences in Decision Making within a Post-acute Psychiatric Clinic

To be submitted to Patient Preferences and Adherence Journal
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Abstract
Severe mental illness in adults refers to a group of mental health conditions including
schizophrenia and schizoaffective, bipolar and major depressive disorders. These conditions are
often characterized by recurring symptoms, multiple hospitalizations, and significant disability.
The public health concern with these conditions is amplified because many individuals with
severe mental illness fail to engage in outpatient treatment. Desperately needed are ways to
support greater rates of participation in outpatient treatment. Encouraging participation in
medical decision-making is viewed as one method to optimize patient empowerment, increase
engagement in care and decrease the negative outcomes that often characterize this
population. Shared decision-making is a collaborative and structured approach to patientprovider communication viewed as a negotiation between mutual experts with the goal of
balancing empirical information with patient values and preferences. As part of an engagementfocused research study, data on decision making preferences and a variety of clinical,
demographic and communication variables were collected from 258 individuals with severe
mental illness during a baseline visit at a clinic serving individuals immediately after hospital
discharge. The association between clinical, demographic and communication characteristics and
patients’ self-reported decision-making preference (active, collaborative, or passive) were
examined using chi square and one-way analyses of covariance. Results indicated that
race/ethnicity was significantly associated with SDM preference group, with African American
individuals desiring more active participation in decision making compared to their Hispanic
counterparts. Other characteristics including age, gender, symptom acuity, diagnosis, insight into
illness, patient and provider agreement on communication during the visit and patient rating of
communication during the visit were not significantly associated with the patient’s baseline
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decision-making preferences in this context. These findings indicate race/ethnicity may be an
important factor when using a shared decision-making approach. More research is needed to
determine how decision-making preferences relate to other clinical or situational factors.

Keywords: Severe Mental Illness, Mental Health, Shared Decision Making, Control Preferences
Scale, Transitional Care Clinic
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Introduction

Severe mental illness in adults refers to a group of mental health disorders often defined by
length of illness duration and the resulting functional impairment it produces. These illnesses
include disorders that produce psychotic symptoms, such as schizophrenia and schizoaffective
disorder, and severe forms of affective disorders, such as major depression and bipolar disorder.1
It is estimated that 4.6% percent of the United States adult population is diagnosed with one of
these conditions at any given time.2 Severe mental illness is one of the leading causes of
disability worldwide according to the global burden of disease disability weights. 3,4 The course
of this group of disorders is often characterized by recurring exacerbations and multiple
hospitalizations.5

The per patient lifetime burden of serious mental illness is estimated at $1.85 million.6 Services
with the highest costs include hospitalization and emergency department visits. In an extensive
review of psychiatric admissions to 418 U.S. community-based hospitals, the three most
common diagnoses included depression (27.8%), schizophrenia/schizoaffective disorder (19.5%)
and bipolar disorder (19.4%).7 These diagnoses are included in the broader category of severe
mental illness. Typical psychiatric hospitalizations for individuals living with severe mental
illness last only a few days (x̅ = 4.4 – 11.1),7 while many still experience severe psychiatric
symptoms at the time of discharge. The recurring hospitalization and emergency care
utilization—as part of ongoing illness management coupled with an over-burdened outpatient
mental health service care system8—result in as many as one-half of these individuals failing to
connect to sustained outpatient care.9 This places patients at greater risk of numerous negative
outcomes, including repeated emergency department visits and inpatient hospitalizations,
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homelessness, violence against others and suicide.10,11 According to Pasic and colleagues
(2005),12 high utilization of hospital and emergency services points to quality of care and access
problems in outpatient care that must be addressed. To this effect, it has been suggested that
these negative outcomes may decrease within the mental health population if patients have more
involvement in psychiatric decision making.13,14 Correspondingly, engagement in outpatient
services may be enhanced with a higher level of patient empowerment within the patientphysician dyad.15

Various intervention approaches have been used to increase follow-through attendance at
outpatient treatment,16 but most methods do not emphasize the importance of patients
participating in their own treatment decisions. Shared Decision Making (SDM) is an exception.
SDM is a structured method to patient-provider communication in medicine that frames the
interaction as a negotiation between mutual experts and stresses the balanced use of empirical
information and patient preference in decision making.17 SDM is a systems approach to enable
continuous improvement in clinical decision making.18 The model focuses on two key
participants, the patient and provider. There is a fundamental social nature in the decisionmaking task that cannot be completed by the doctor or patient alone, but rather requires
productive interactions and communication between them. In a shared decision-making model,
clinical providers are primarily responsible for knowing and appropriately applying the
knowledge base. Patients are primarily responsible for contributing well-informed subjective
assessments of possible health states relevant to decisions and for reporting outcomes and
experiences with, and assessment of, these health states. Patients are additionally tasked with
providing their values and preferences related to medical decisions. The responsibility placed
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upon key participants is high, but that responsibility also lies at the center of success in such a
model. Additionally, current clinical practice guidelines advocate for all clinicians, regardless of
public health sector, to involve patients in decision making processes and allow for patient
preferences, along with the evidence, to guide decisions where possible.

Research on SDM in psychiatry has received support through the New Freedom Commission on
Mental Health,19 and other government policy reports.20,21 SDM may be of particular benefit in
severe mental illness because of low follow-through with treatment due to factors including
dissatisfaction with side effects from antipsychotic and mood stabilizing medications, poor
insight into illness, and functional and motivational impairments. Despite these challenges, the
majority of people experiencing mental illnesses express a desire to participate in making
decisions regarding medications and hospitalizations,22-25 and there is evidence that adults with
severe mental illness frequently make competent and prudent treatment decisions.26,27 Drake and
colleagues (2010)28 pose that SDM is an essential component in treatments focusing on recovery
for individuals with severe mental illness, calling it an ethical imperative. Despite the apparent
promise of SDM, there is a low level of adoption and implementation of this practice within the
mental health care delivery system, relative to other areas of medicine. Efforts to increase patient
involvement in care decisions face barriers such as overworked physicians, insufficient provider
training, deficient medical information systems, physician time constraints, perceived lack of
efficiency in the practice, a deemed lack of applicability due to patient characteristics and
symptoms, and inappropriate clinical situations.29,30 Slade (2017)31 also cites a lack of support
tools, integration of SDM with other recovery‐related interventions, and sensitivity to cultural
changes as problematic for SDM implementation in mental health.
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At the patient level, demographic characteristics may make someone more or less interested in
participating in this collaborative approach. In a review of patients’ preferences for involvement
in decision making, research revealed demographic variables, including being younger, better
educated and female were consistently found to be associated with a preference for a more active
role in decision making.32 However, in a comparison of older and younger individuals with
severe mental illness, it was concluded older persons have a stronger desire for involvement in
decision making than do their younger counterparts.23 Demographics related to decision making
preferences within this population remain unclear.

A better understanding of the factors related to shared decision-making styles for different
patients, and a better understanding of issues related to its implementation may be critical to
maximizing individual patient outcomes. Currently, there is insufficient evidence on how much
involvement individuals with severe psychiatric conditions desire to have in their patientprovider interactions regarding psychiatric care decisions. While previous studies have found
factors such as age and gender to impact the desired level of involvement in care, results are
inconclusive. Moreover, there is no evidence to date on how factors such as the level of
psychiatric symptomatology, level of insight and ethnicity are related to patient’s preference for
involvement in the process of treatment decisions. A Cochrane review on the use of SDM in the
mental health population highlighted the necessity for more research in this area.33

Materials and Methods
Setting and Design
The study site was the Transitional Care Clinic (TCC) providing a wide range of services to
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individuals recently discharged or deferred from a psychiatric hospital or crisis setting. Services
provided include medication management, evidence-based psychotherapy and case management
for individuals with severe mental illness. Between the years of 2014 and 2016, a research study
was conducted on the effects of engagement-focused care versus usual care (Patient-Centered
Outcomes Research Institute (PCORI); Contract number: IH-1304-6506). A key component in
engagement-focused care was training in, and use of, SDM practices by all clinic providers prior
to study initiation. As part of the engagement-focused research, data on decision-making
preferences and a variety of clinical, demographic and communication variables were collected
from 258 individuals with severe mental illness during a baseline visit at a clinic serving
individuals immediately after hospital discharge.

Participants
The patient sample included a convenience sample 258 individuals with severe mental illness
who attended a post-acute psychiatric hospitalization appointment at the Transitional Care Clinic
as participation in the parent study. By virtue of their acceptance into this clinic, participants are
over 18 years of age, have been recently discharged from an inpatient psychiatric unit or triaged
from an emergency room, and received a diagnosis of severe mental illness. One participant was
missing over half of the study data and was excluded from analyses. Patient follow-up
appointments at the clinic typically occurred 1-14 days post discharge. Severe mental illness is
defined as a Diagnostic and Statistical Manual of Mental Disorders – 5th Edition (DSM-5)34
primary diagnosis of schizophrenia, schizoaffective disorder, bipolar disorder (with and without
psychotic features), depression (with and without psychotic features), unspecified psychosis and
unspecified mood disorder. The analyses of pre-existing data for this research study was
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approved by both the UT Health Houston Committee for the Protection of Human Subjects and
the UT Health San Antonio Institutional Review Board.

Data Sources and Measures
Demographic Data: Patient level demographic data available for analyses included age, ethnicity,
gender and diagnosis as charted at the time of first clinic appointment immediately following
hospital discharge.

Control Preferences Scale (CPS). Patient preference for participation in SDM is was measured
with the Control Preferences Scale.35 The control preferences construct is defined as "the degree
of control an individual wants to assume when decisions are being made about medical
treatment".35 This scale presents patients with five cards that each present a statement describing
a different role in decision making. Statements range from, I prefer to make decisions about
which treatment I receive to I prefer to leave all decisions regarding my treatment to my
doctor. Cards are presented to the patient in pairs in a pre-specified order (B, D, C, A, and E)
until the five statements are rank ordered. Sorting produces six different possible categorizations
of how involved patients want to be in decisions. These include: 1) Active-Active, 2) ActiveCollaborative, 3) Collaborative-Active 4) Collaborative-Passive 5) Passive-Collaborative and 6)
Passive-Passive. For the purposes of the current study, we collapsed the six classifications into
three: Active (Category 1-2), Collaborative (Categories 3-4), and Passive (Categories 5-6). For
analysis of control preference data, we combined categories from the Control Preferences Scale
into three larger groups reflecting their preferred SDM style; 1) Active, 2) Collaborative and 3)
Passive. The primarily Active Group includes those patients who fell into either the Active-
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Active or Active-Collaborative categories. These patients tend to prefer to make most of the
decisions with very little or no input from the doctor. The Collaborative Group includes patients
who fell into either the Collaborative-Active or Collaborative-Passive categories. These patients
prefer a very collaborative interaction where decisions are equally based on doctor patient input.
The primarily Passive Group includes those patients who fell into either the PassiveCollaborative or Passive-Passive categories. These patients prefer interaction where their doctor
has the majority of weight in decision making.

Matched Pair Instrument (MPI). Patient and prescriber ratings of prescribers’ in-session
communication was obtained using the Matched Pair Instrument36 a dyadic instrument
comprised of 19 statements that assess the content and process of a prescriber’s communication
skills from each patient’s perspective. Each skill on the MPI is rated on a 5-point scale with
higher scores indicating stronger agreement with the statement. The prescriber and patient
completed a version immediately following the baseline study encounter. A total score for each
participant is derived. In addition, a difference score between provider and patient ratings was
calculated. The absolute value of this score reflected the average distance between patients and
providers in their perceptions of communication during the session.

Expanded Brief Psychiatric Rating Scale (BPRS). The Expanded Brief Psychiatric Rating Scale
(BPRS) was used to characterize psychiatric symptoms amongst patients37 This scale is a 24item interview-based measure that captures a range of psychiatric symptoms rated on 7-point
Likert scales, with higher scores indicating more severe symptomatology. This scale is summed
to yield a total score and several factor scores (depression-anxiety, positive symptoms, and
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negative symptoms).

Scale to Assess Unawareness of Mental Disorders (SUMD). The abridged version of the Scale to
Assess Unawareness of Mental Disorders38 was used measure patient insight into having a
psychiatric illness. This semi-structured open interview evaluates three items including global
insight, insight into illness and insight into symptoms on a series of 5-point Likert scales with
higher scores indicating lower insight.

Data Analysis
Univariate descriptive statistics included means with standard deviation and frequencies for all
variables. For analysis of control preference data, we combined categories from the Control
Preferences Scale into three larger groups reflecting their preferred SDM style; 1) Active, 2)
Collaborative and 3) Passive. We present numbers (percentages) of participants in each of the
three collapsed control preference groups.39

Chi square analyses were used to examine Shared decision-making classification
(Active/Collaborative/Passive) by gender (Male/Female) and ethnicity (name here) to determine
whether there was an increased likelihood that one gender or specific ethnic group preferred
specific styles of medical decision making. As only four patients classified their race as “other”
or “mixed” (causing expected frequencies in the associated cells to be too low), we excluded this
group and the “unknown” group from subgroup interaction analyses, focusing the examination
on the relationship between race/ethnicity (non-Hispanic white, Hispanic, African American) and
the three SDM control preference groups (Active, Collaborative, and Passive).
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To test the main effects and interaction one-way analyses of covariance were used examining
control preference group differences (Active/Collaborative/Passive) on continuous measures
including age, clinical symptomatology (BPRS total score and subscale scores), insight into
having a psychiatric illness (SUMD total score), matched pair difference scores and matched pair
patient ratings. All tests were two-tailed. Demographic and clinical data were used to determine
if differences exist between groups of patients who desire differing levels of involvement in
psychiatric decision making. The measures of communication allowed for examination of how
patients view the initial encounter with prescribers, and the extent to which their view of the
encounter differs from that of the prescriber.

Results
The sample was 45.4% male (117/257); with a mean age of 38 (S.D. 11.9). 50% were Hispanic
(129/258), 38% non-Hispanic white (99/257), 8% African American, and 3% other or unknown
(8/257). Almost 40% were diagnosed with major depressive disorder (103/257), followed by
30% with bipolar disorder (78/257), 16% with unspecified mood disorder (42/257) and 14% with
schizophrenia and related disorders (including schizoaffective disorder and unspecified
psychosis; 35/257). Twenty-six percent (68/257) of the sample identified as having active control
preferences – desiring all or most decision-making responsibility, 53% (137/257) as
collaborative – sharing most decision-making opportunities, and 21% (53/257) as passive ceding most or all decision making to the provider. Demographic characteristics and SDM
control preference categories are summarized in Table 1.1
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Table 1.2 presents a breakdown of SDM preferences by race/ethnicity. Race/ethnicity
demonstrated a significant relationship with patient control preference group (X2 (4; N=257)
=10.18, p =0.0375). A significant difference was found in medical related control preferences
between African American and Hispanic individuals, with African American individuals
preferring a more active role than did their Hispanic counterparts (X2 (1; N=249) =3.97, p
=0.0463). Odds ratio estimates revealed African American individuals are 4.17 times more likely
than are Hispanic individuals to be in the Active group (1/.241=4.17). No significant differences
were found for control preferences between Hispanic and non-Hispanic whites or between
African Americans and non-Hispanic whites.

No other demographic or clinical variables investigated distinguished the control preference
decision-making groups. We examined the contribution of gender, age, clinical symptomatology
(BPRS total and depression-anxiety, positive symptom and negative symptom subscales),
diagnosis, patient rating of communication satisfaction, and patient/provider communication
satisfaction agreement and found no significant relationships to SDM preferences (all p values >
.o5*). A multinomial logistic regression with stepwise selection was then used to include
variables with a 0.3 significant level for entry into the model. No differences were found
between the three control preference groups by gender (X2 (2; N=257) =0.643, p =0.725), age (X2
(2; N=257) =0.089, p =0.957), depression-anxiety subscale (X2 (2; N=257) =2.238, p =0.327),
positive symptom subscale (X2 (2; N=257) =3.979, p =0.137), negative symptom subscale (X2 (2;
N=257) =0.246, p =0.884), patient communication satisfaction (X2 (2; N=257) =0.466, p
=0.792), or provider-patient communication satisfaction (X2 (2; N=257) =0.821, p =0.664).
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Discussion
This study contributed to the limited published literature on shared decision making within the
mental health field. Additionally, this is the first study to investigate the medical decision control
preferences in a group of individuals receiving mental health treatment immediately following
hospital discharge. Race/ethnicity is an important factor when using a shared decision-making
approach. African American individuals were more likely to want to be active or collaborative
contributors in the medical decision-making process. There is a complex history of race in the
medical profession. Doctors have historically been Caucasian and there is a history of
exploitation of African American Americans as well as perhaps engaging this population with
directives rather than dialogue. This may have led this population to be more suspicious of
providers and, consequently, the desire to more actively participate in medical decision-making.
Many disparities are reported in the area of mental health when comparing African Americans to
whites, including higher levels of incorrect diagnoses, underrepresentation in research, less
access to treatment, more severe symptom ratings, greater functional impairment once
diagnosed, and significantly fewer African Americans seeking treatment.40-43 Additionally,
Eliacin et al (2016)44 reports African Americans are less likely to be engaged in treatment and
often perform more poorly on healthcare activities linked to patient engagement, such as
communicating effectively with providers and participating in treatment decisions. To this end,
active engagement and participation in mental health treatment may represent an important
component in addressing many of these inequalities. For example, providers may work to
increase patient activation by asking patients to define their goals for mental health treatment
including the steps needed to achieve them and identify patient knowledge gaps so further
education can be offered. In contrast to African Americans, Hispanic individuals were more
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likely to choose a passive role in decision-making. From a historical perspective, Hispanic
individuals tend to be respectful of authority and more likely to adhere to a perceived power
gradient, making them more likely to cede decision making to a medical provider.45,46 Research
indicates Hispanics are more deferential to authority figures, depending on acculturation, and are
less likely to engage in mental health treatment than whites.47 For these reasons, Añez et al
(2008)48 proposed the application of motivational interviewing principles to Latino cultural
values and emphasizes the need to promote a client-centered and culturally congruent therapeutic
environment to improve the connection to and participation of these individuals. Markowitz et al
(2009)49 suggests minimizing the emphasis of the medical diagnosis and recognition of the
centrality of family as necessary cultural adaptations when treating Spanish-speaking individuals
with depression. Providers may also work to improve their Hispanic patients’ self-efficacy in
making sound medical decisions by dividing tasks and offering feedback and reinforcement for
each aspect of illness self-management. It is evident that baseline decision making preferences
need to be considered when providing mental health care. Patients of all races/ethnicities need to
be aided on how to engage in the process of SDM and providers need to ensure they
communicate the importance of active and collaborative participation, even in situations that
may be new for individuals in treatment. This may involve recognizing the patient’s knowledge,
allowing sufficient time for participation or explaining the benefits of participating in treatment
including improved health outcomes and better quality of life.50 In line with the emerging
paradigm of patient-centered care, culturally appropriate decision making needs to be
emphasized. This may include decision aids and coaching manuals with culturally congruent
language and examples and further training for mental health professionals.
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Race/ethnicity is an important consideration when using a shared decision-making approach, yet
other demographic, clinical and communication characteristics were not predictive of control
preference style in this context. It may be other factors are more important in determining the
extent to which someone wants to contribute in psychiatric decision making. The participants in
this study had in common a recent acute psychiatric hospitalization or crisis. Perhaps given this
often traumatic and stressful event, other characteristics, such as age, gender and symptom acuity
become less important as related to shared decision-making preferences. In a review of nonpsychiatric patient preferences for involvement in medical decision making, Say et al (2005)32
report demographic variables, including being younger and female as consistently associated
with a preference for a more active role in decision making. These findings were not
corroborated in this study, although it may hold true for the general population. Other possible
explanations not explored in this study include previous experiences in the mental health system,
including hospitalizations, and personality traits.

Previous experiences with the mental health system may affect how individuals interact with
current and future providers of care. In a group of 588 individuals with severe mental illness in
Europe, Cosh et al (2017)40 report a significant association between active (versus collaborative
or passive) involvement in decision making and longer hospitalization durations.
Correspondingly, these authors report patient-rated preferences for passive or shared decision
making styles were associated with shorter hospital admissions.40 This finding suggest that
patients with less severe illnesses, who are less likely to have inpatient admissions, prefer sharing
decision making with providers while those with more severe illnesses prefer additional input in
decisions. The number and length of previous hospitalizations were not evaluated in this study
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and future research should examine whether active decisional preference is a marker of patients
who are less well or whether there is a causal association between active decision preferences
and more hospital admissions. Apart from experiences in the mental health system, research
suggests personality traits such as, extraversion, agreeableness, conscientiousness, neuroticism,
and openness to experience are related to desire to make medical decisions.51 Flynn (2007)52
found that higher rates of conscientiousness and openness to experience and lower levels of
agreeableness and neuroticism related to preferring the most active decision-making style
compared with the least active decision-making preference. These studies demonstrate the need
to examine personality characteristics when studying decision-making preferences.

Limitations
Multiple tests of statistical significance were utilized in these analyses and may have increased
the likelihood that the relationship between race/ethnicity and control preference group was due
to chance. The cross-sectional nature of this study did not allow for examination of difference in
SDM styles over time. A relatively smaller percentage of African American study participants
make it difficult to generalize from these results. The control preference groups were determined
by one self-reported assessment. While the Control Preferences Scale is a validated instrument, it
is possible that more sensitive scales or use of more than one scale is needed.

Conclusion
Despite the limitations described above, the study highlighted that SDM preferences are different
across individuals in this treatment setting. These preferences need to be considered in
approaching SDM education for patients and providers and in creation of culturally informed
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decision aids and manuals. The concept of shared decision making is not a new one, however,
we are experiencing a paradigm shift with more emphasis in self-directed care in the mental
health system. Both providers and patients want to share in medical decision making, but neither
may be completely certain how to appropriately engage in collaborative exchange. This may be
especially true for providers and their patients who have recently been discharged from an
inpatient setting. Using culturally congruent decision aids and increasing patient activation and
self-efficacy in making medical decisions may be viable methods of engaging individuals in
care, thereby increasing collaborative decision-making. SDM has been demonstrated to improve
outcomes for people across many areas of mental and physical health and must be implemented
with thoughtful consideration of patients to realize its full potential. More research is needed as
this is the first published attempt we are aware of to examine these demographic, clinical and
communication variables within this population.
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Table 1.1 Demographic characteristics and SDM collapsed control preference category
(N=257)
Characteristic
N
%
Race or ethnicity
Non-Hispanic White

99

38.4

Hispanic

129

50.0

African American

21

8.3

Other/Mixed

5

1.9

Unknown*

3

1.1

117

45.35%

Major Depressive D/O

102

39.7

Bipolar Disorder

78

30.3

Unspecified Mood D/O

42

16.3

Schizophrenia & Related D/O

35

13.6

37.95

11.9

Active

67

26.1%

Collaborative

137

53.3%

Passive

53

20.6%

Male
Diagnosis

Age (M±SD years) (range 18-66)
Collapsed SDM preference category

*Note: Data not captured at first visit and patient did not return to clinic, so data remains unknown

Table 1.2 Breakdown of SDM preferences by race/ethnicity (N=257)
Race/Ethnicity
Active N (%)
Collaborative N (%)
Passive N (%)
Non-Hispanic white

27 (27.3)

58 (58.6)

14 (14.1)

Hispanic

26 (20.2)

67 (51.9)

36 (27.9)

African American

9 (42.9)

9 (42.9)

3 (14.3)

Other/Mixed

4 (1.6)*

1 (0.4)

0 (0.0)

Unknown

1 (0.4)

2 (0.8)

0 (0.0)

*Note: There is a possibility these 4 patients are a mix of African American, thereby increasing the overall
likelihood of African Americans choosing a more active role in decision-making.
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Abstract
There is increased interest over the last decade in the use of Shared Decision Making with
individuals with serious mental illness to improve engagement in treatment and patient
outcomes. We conducted semi-structured qualitative interviews with 15 individuals with serious
mental illness treated in an outpatient transitional care clinic serving people immediately after
discharge from a psychiatric hospitalization. Parallel interviews were conducted with a variety of
clinical providers (n = 9). Using latent thematic analysis six themes were identified including: 1)
Differences in the Use of SDM, 2) Consideration of Past Experiences, 3) Decisional Power
Preferences, 4) Use of SDM in Psychiatry Versus Other Areas of Medicine, 5) Dignity and
Disengagement, and 6) External Forces Impacting SDM. Implications for clinical practice and
research using a shared decision-making approach within this treatment setting are further
discussed.

Keywords: Severe mental illness, serious mental illness, shared decision making, transitional
care clinic, mental health
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Introduction
Engagement in mental health services following psychiatric hospitalization is of critical
importance for improving the lives of individuals with severe mental illness and reducing long
term negative outcomes, such as hospitalization, homelessness and suicide (Velligan, 2009; Pasic
et al, 2005). Patients who feel they are playing an active role in their treatment typically have
better engagement and outcomes than patients who experience themselves as passive recipients
of care (Alegrai, et al, 2014; Stewart, 2001). Although various intervention approaches have
been used to increase engagement in outpatient treatment in serious mental illness (Roberts,
2011), most methods do not emphasize the importance of patients participating in their own
treatment decisions. Shared Decision Making (SDM) is an exception. SDM is a structured
approach to communication in medicine that frames the interaction as a negotiation between
mutual experts (patient and provider) and stresses the balanced use of empirical information and
patient preferences and values in decision making (Charles, 1997). SDM is compatible with
evidence-based medicine in its emphasis on the use of empirical information to make treatment
decisions (Guyatt, 2001), and with the serious mental illness consumer recovery movement in its
emphasis on patient-centered care (Drake, 2010). Furthermore, the process of recovery from
mental health conditions depends on patients taking personal accountability for medical
decisions, including those about medications and types of therapies.

SDM is well operationalized, with specific components and clinician competencies detailed in
the literature (Campbell, 2007; Elwyn, 2005). Several of the fundamental SDM principles aim to
help the individual in treatment become more aware a medical decision is needed, offer more
than one option from which to choose, communicate the pros and cons of the different options
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and support the patient to make informed choices (Sepucha et al, 2010). A shared decisionmaking method recognizes the expertise gleaned from both providers and patients in making a
joint decision. Additionally, research trials demonstrate interventions involving SDM are feasible
and well tolerated by individuals with serious mental illness (Deegan, 2006; Hamman, 2011).

Barriers to SDM Implementation and Dissemination with Serious Mental Illness
Despite the apparent promise of SDM, there is a low level of adoption and implementation of
this practice within the delivery of mental health care, relative to other areas of medicine
(Pollard, 2015; De las Cuevas et al, 2013; Drake et al, 2010; Hamann et al, 2006). Whether in
physical medicine or mental health, efforts to increase patient involvement in decisions about
their care face barriers such as overworked physicians, insufficient provider training, deficient
medical information systems and physician time constraints (Legare, 2008; Towle, 2006).
Specific to psychiatry, further complexity is introduced with the potential lack of applicability of
SDM due to patient characteristics and inappropriate clinical situations (Solbjør et al, 2013).
From the standpoint of efficiency, when SDM is used in prescriber-patient interactions, visits are
perceived by prescribers to take more time than does a standard psychiatry appointment (Burton,
2010) and doctors cite this as one factor that limits their use of SDM (Legare, 2008).

Despite a desire to know more about their diagnosis, treatment options and side effects (Hamann
et al, 2007; Drake et al, 2010), patients receiving psychiatric care report that prescribers often do
not provide sufficient information or explain it in an understandable manner (Lorem et al, 2013;
Garfield, 2004). Attitudes about the use of SDM have been found to differ by profession, with
physicians being more likely than occupational therapists and pharmacists to communicate about
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the pros and cons of medical issues (Chong et al, 2013b). At the patient level, difficulties in
using SDM may be due in part to illness-related information processing challenges of the
individual in treatment (Mahone, 2011; Hamann et al, 2011; Chong et al, 2013; McCabe et al,
2013), suggesting the need for the use of decision support aids and other scaffolding techniques
to aid patient preferences in decisions about their care (Deegan, 2006) that may be different from
those used for non-mental health patients.

Facilitators of SDM Implementation and Dissemination in Serious Mental Illness
Evidence supports the use of SDM for individuals with serious mental illness (Hamman, 2011;
Drake, 2010; Deegan, 2006). Research on SDM in psychiatry has received support through the
President’s New Freedom Commission (PNFC) on Mental Health and other important
government policy reports supporting the notion that transformation of the mental health service
delivery system to promote recovery hinges on treatments that give individuals real and
meaningful choices about treatment options (President’s New Freedom Commission, 2003;
Institute of Medicine, 2001). SDM may be of particular benefit in serious mental illness because
of the high incidence of patient non-adherence with treatment due to factors including
dissatisfaction with side effects from antipsychotic and mood stabilizing medications, poor
insight into illness and functional and motivational challenges. For individuals who decline to
take medications, SDM may constitute a reasonable approach to remaining engaged with care
providers allowing them to take advantage of treatment options such as case management or
psychotherapy, while continually re-evaluating the potential role of medication. For patients with
poor insight or functional challenges, SDM represents a non-threatening approach to clarifying
motivations and options for improving quality of life. Despite evidence of cognitive challenges
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and problems with insight, there is evidence that adults with serious mental illness frequently
make competent and prudent decisions (MacDonald et al, 2017). For example, in studies of
decisional capacity, individuals with schizophrenia (Carpenter et al, 2000) and severe depression
(Lapid et al, 2003) performed as well as their non ill counterparts on measures of ability to
provide informed consent following an educational intervention (Carpenter et al, 2000).
Additionally, the Institute of Medicine (IOM) rebutted the belief that this group of individuals
should be assumed to have impairment in decisional capacity when stating, “many people with
mental illness, indeed, many with severe mental illnesses, are not incompetent on most measures
of competency” (IOM, 2006, p. 112). Despite frequent behavioral passivity, patients with
serious mental illness express a strong desire to be informed about their illness and treatment
options, and to be active participants in their treatment decisions (Velligan et al, 2017; Adams,
2007; Arora, 2000; De las Cuevas, 2013). Similarly, mental health providers report positive
attitudes toward SDM (Seale et al, 2006; Hamann et al, 2009).

Despite promising data on the use of SDM, the uptake of this practice is poor within services
provided to the seriously mentally ill population (Pollard, 2015; De las Cuevas et al, 2013; Drake
et al, 2010; Hamann et al, 2006). The aim of this study was to identify the factors influencing the
use of a shared decision-making model in a transitional care clinic providing treatment to
individuals with serious mental illness after a psychiatric crisis or hospitalization.

Methods
Design
We conducted one-on-one explorative interviews with individuals in treatment and a variety of
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clinical providers. Fifteen patients and nine providers participated in one-on-one interviews
describing their experiences with medical decision making in at the Transitional Care Clinic and
in comparison to previous treatment settings. Topics addressed during patient interviews
included experiences with prescriber interactions and impact of the SDM process on medication
visit outcomes and recovery. Providers discussed experiences using SDM as a practice in general
and, specifically about feasibility and utility for individuals seeking care at the Transitional Care
Clinic. The interviewer followed a semi-structured interview guide starting with broader
questions and ending with more focused discussions on specific topics.

Setting and Sample
The study site was a Transitional Care Clinic funded by area hospitals, charitable organizations
and an 1115 Medicaid Waiver. The clinic provides a wide range of services including medication
management, evidence-based psychotherapy and case management for individuals with severe
mental illness recently discharged or deferred from a psychiatric hospital or crisis setting. Severe
mental illness is defined as a DSM-5 primary diagnosis of schizophrenia, schizoaffective
disorder, bipolar disorder (with and without psychotic features), depression (with and without
psychotic features), unspecified psychosis and unspecified mood disorder. As part of an
engagement-focused research study conducted from 2014 and 2016 at the Transitional Care
Clinic (Patient-Centered Outcomes Research Institute [PCORI]; Contract number: IH-13046506), all clinic providers were trained in SDM and continue to be trained in this modality.
Provider participants were recruited via email from the first author requesting participation in the
study. The nine participating providers included three psychiatrists, one nurse practitioner, one
nurse, two psychologists (also served as clinic administrators) and two therapists. Patient
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participants were recruited during regular medication clinic visits on two separate days in
September, 2019. Individuals presenting at the clinic were asked by clinic staff about their
interest in participating. All patients had capacity to provide consent. Interviews for patient and
provider participants were conducted by the first author and lasted approximately 20-40 minutes.
All interviews were conducted at the clinic and patient participants were paid $30 for their time.

Data Collection
Demographics were obtained from the patients and provider participants including age, gender
and ethnicity. The semi-structured interview was developed by the authors (NM and DV) in
collaboration with experts in the Department of Psychiatry and Behavioral Medicine, and the
stakeholder advisory board of the Transitional Care Clinic. Topics addressed included the
patients’ experiences and satisfaction with prescriber interaction, impact of the SDM process on
medication visit outcomes and comparisons to previous healthcare experiences. The provider
interview guide consisted of questions about experiences using SDM as a practice within the
Transitional Care Clinic, including feasibility, and utility. The interview guide began with broad
items to allow the participant to begin thinking about their experiences with SDM, what this
method entails, their role in the decision-making process, and the information needed to make
this approach successful. The interview then moved on to questions regarding how SDM affects
participation in sessions and the impact on outcomes and recovery. All questions were openended. For patient participants who displayed distractibility or difficulty understanding,
questions were reworded or repeated. After conducting the fifteen patient and nine provider
interviews, it was apparent that similar themes were discussed, and no new themes were
emerging. Therefore, saturation was deemed to be reached and no further interviews were
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conducted. The research study was approved by both the University of Texas Health Science
Center at Houston Committee for the Protection of Human Subjects and the University of Texas
Health Science Center at San Antonio Institutional Review Board.

Data Analysis
Interviews were audio recorded and transcribed by research staff and were coded by two authors
(NM and DV). Latent thematic analysis was used to analyze this exploratory data (Braun &
Clarke, 2006)) and NVivo 12 software was used to organize the data (NVivo 12, QSR
International Pty Ltd, 2018). Each participating group (patient and provider) was analyzed
independently and then the group data were combined. Using inductive category development,
the codes from all transcripts were thematically clustered to serve as the basis for higher level
categories, of which there were 12. Inductive categorization allowed for coding the data without
trying to fit it into a pre-existing coding frame, or the researcher’s analytic preconceptions
(Braun & Clarke, 2006). This flexible method is used to identify patterns of meaning within data
among participants and is not allied to any particular framework. We looked for themes
especially relevant to differences in experiences of and preferences for SDM (e.g. desired
balance of power); satisfaction with provider visits, including length of visits; how previous
experiences affect current desire for and use of SDM; and consequences of not using an SDM
approach. All codes were then grouped into these categories by the two researchers. Following
thematic latent analysis (Braun & Clarke, 2006), the 12 semantic categories were further
analyzed at the latent level to identify higher order themes, of which there were six. Any areas of
disagreement were resolved by discussion until consensus was reached.
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Results
Sample Characteristics
Of the patient participants, ten were female, four male and one nonbinary. Eight were white
Hispanic, six were white non-Hispanic and one was African American. Participant
characteristics can be seen in Table 2.1. Analysis of patient and provider interviews resulted in
six major themes: 1) Differences in the Use of SDM, 2) Consideration of Past Experiences, 3)
Decisional Power Preferences, 4) Use of SDM in Psychiatry Versus Other Areas of Medicine, 5)
Dignity and Disengagement, and 6) External Forces Impacting SDM.

Six Themes
A number of important themes emerged from the research. Exemplary quotes from each theme
can be viewed in Table 2.2.

Differences in the Use of SDM
A primary reason in attending appointments at the Transitional Care Clinic is to receive
medication for mental health conditions, although many other treatments may be provided in
addition to medication management. Specific to discussions of medication, the majority of
comments from both patients and providers support the active provision of options including,
research data, weighing pros and cons, and collaborative communication. Discussions around
medication occur in most medication follow-up visits, even if no changes are needed or made.
One patient participant recalled wanting an increase in medication, but that request was not
fulfilled. However, a joint discussion still transpired. Prescribers typically offered options each
time a medication or therapy was not satisfactory to the patient, whether due to side effects,
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potency, or other reasons, and patients were pleased with this communication method. Providers
and patients concur that the final decision on taking medication and deciding which medication
to take is the responsibility of the patient, although the clinical provider is heavily relied upon for
their expert knowledge. The respect given to provider knowledge was apparent from the vast
majority of patient participants (12/15). Three patients described the experience of not feeling
like a partner in decision making at the Transitional Care Clinic, recounting a lack of perceived
power and an absence of a give-and-take conversation around treatment. All interviewed
providers endorsed seeking to use a SDM approach, although none endorsed explaining the
actual concept or methodology of SDM with patients. Decision aids (media or methods that
inform patients about treatment options) are not regularly used by any interviewed providers to
assist patients in making decisions, and only three patient participants endorsed a positive
attitude about their potential use in mental healthcare.

Consideration of Past Experiences
All patient participants discussed experiencing any number of severe symptoms, such as
psychotic episodes, debilitating depression, attempts at self-harm, and brief or long-term
hospitalizations. Many (11/15) described previous negative experiences during psychiatric
hospitalizations where they perceived having no input on anything, for example, daily schedule,
medications taken and discharge date. These experiences created a perception of having no
power in these situations. Similarly, providers discuss creating a “disempowered” group of
patients because of these types of negative inpatient experiences. Providers further explained
these negative, and often traumatic, experiences with no opportunity for input or perceived
control shaped how patients believe they may or may not participate in their healthcare
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management. They also refer to health disparities often present in the severely mentally ill
population, including economic disadvantage, lack of access to healthcare and lower levels of
education, as being interrelated to patients’ perceptions and understanding of mental healthcare.
Providers acknowledged patients may not “know how to ask to be an equal partner” in their
mental health treatment because they have essentially been trained not to do so. Comparably,
providers also discussed differences in their own education and background influencing their
beliefs about a SDM approach to care. There is a difference of opinion amongst providers as to
the extent to which SDM is taught to mental health professionals during their formal education.
The collaboration is more required for some job roles and providers acknowledged the use or
uptake of a SDM approach may be generational, in that more newly trained providers may have
received more education on this communication method.

Decisional Power Preferences
Both groups of participants agreed the patient and provider should share decision-making
responsibility and many patients cited “50/50” as the appropriate balance of decision-making
accountability. Most providers conveyed the patient should have more than 50% of the
decisional authority (i.e. 60/40, 75/25), although two stated the situations and decisions varied
too much to approximate a percentage. Two providers also introduced the importance of
significant others in the patients’ lives, such as family members, who are part of the onus to
providing input for health-related decisions. While most patient participants prefer nearer to an
equal partnership, a small number (3 of 15) preferred to concede power to the provider. These
three were all white Hispanic females.
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Use of SDM in Psychiatry Versus Other Areas of Medicine
The use of SDM in psychiatry was viewed as more important than its use in non-mental health
settings. Providers often cited the lack of a specific test or scan to diagnose and treat ailments.
“We don’t have an x-ray machine.” In these situations, patients participating as their own expert
is of increased value. Patients described the importance of sharing in decisions as the precursor
to a trusting relationship that fosters honesty and recovery. Several patients said they can talk to
their current provider about topics they have never discussed previously with other providers--for
example, repeated childhood trauma. This aligns with providers’ reports that sharing information
is the best way to proceed with appropriate treatment options. The information on how someone
is feeling what they have experienced informs the process of how physicians and therapists make
treatment decisions. Providers mention pre-established guidelines for medication and therapies
based on their knowledge of the case. If patients do not provide accurate or honest information,
providers cannot put those protocols into action. In physical medicine, there is often a clearly
superior treatment option, for instance in cancer treatment, but this is typically not the case in
mental health treatment—thus increasing the reliance on patient involvement. Providers and
patients agree it may take more time upfront to engage in discussions that are essential to a SDM
approach, but all reported this communication practice saves time later. For example, providers
mentioned that extra time spent on discussions within the office may help reduce: 1) extra phone
calls to clinic staff because details were omitted, 2) symptom recurrence and possible
hospitalization, and 3) patient’s experience of unexpected side effects. Likewise, providers did
not believe using a SDM approach uses more resources over the course of treatment. Several
providers mentioned a higher likelihood of patients showing up to appointments as a potential
cost saving aspect of using SDM.
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Dignity and Disengagement
Almost half of the interviewed patients (7/15) describe times, either in this clinic or in previous
experiences, where they did not feel their opinions were taken into consideration and stopped
seeking treatment or taking medication altogether. Patients described specific times where they
requested a change in medication or other treatment and the provider did not consider their
request; there was no attempt at discussion. These patients describe stopping all treatment, which
led some to an increase in symptoms, suicide attempts and hospitalization. Patients and providers
agree it is better to taper off of a medication or other treatment while remaining engaged with
care providers. Possible consequences of not allowing patient input is their disengagement from
the mental health system, self-harm, rehospitalization, or other negative outcomes. While
decisions are sometimes made for individuals in treatment, many (10/15) described being their
own expert and believe their personal knowledge must be considered, even if not pursued. There
is a dignity in risk. While patients understand there may be negative consequences to reducing or
stopping treatment, they want partnership in attaining their health goals, sometimes in opposition
of what the providers believes is best practice

External Forces Impacting SDM
The majority of patients and provider participants support the notion of SDM and its use with
individuals in a psychiatric setting. However, almost all indicated times when a more
paternalistic approach is needed. The need for an authoritative style was linked to recurrent or
worsening symptoms or fear for patient safety, including intent of suicide or homicide. All
providers and all but one patient agreed the clinical provider, often the physician, carries the
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weight of making decisions for the patient when their decisional capacity is impaired due to an
“acute exacerbation of symptoms.” Likewise, providers exert a responsibility to their own
clinical licenses and training that may be in opposition to what patients want. Most providers
listed following clinic (or systemic) rules as a responsibility (i.e., adhering to a rule restricting
the prescribing of benzodiazepines) that may negatively impact the provider-patient relationship
because the decision is out of their hands. Providers and patients agreed a discussion can still
transpire that can minimize the negative feelings associated with not having a full or real choice.

Discussion
This is the first evaluation of the perceptions and preferences of individuals with serious mental
illness and their providers regarding SDM in a clinic serving a population immediately following
a psychiatric crisis or hospitalization. Results of this qualitative study suggest that patients and
providers value SDM, understand its application, and believe it is related to better outcomes.
Several important topics are evident and can inform future clinical care and research in this field.

Implications for Clinical Practice
The study supports the need to ensure that SDM is a routine practice in psychiatric care. Study
participants made comments which are supported by research suggesting that a continued
paternalistic approach in medical decision making continues to socialize individuals into the role
of patient rather than equal partner (Murjic et al, 2015). Patients and providers identified
potential serious consequences including, disengagement and abruptly terminating treatment,
when patients do not participate in decisions and do not feel heard. Studies of SDM link
increased patient involvement to improved treatment adherence and quality of life, while lack of
patient involvement is related to lower adherence to treatment, patient satisfaction, and overall
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health outcomes (Sepucha & Mulley, 2009). The reports that SDM improved show rates and
reduced calls in between appointments is important to patients, providers and the agencies for
which they work. Research continually demonstrates no shows increase overall healthcare costs
and reduce the gains made from treatment (Kheirhah et al, 2016, Berg et al, 2013).

Both patients and providers in this study assert that trust in the clinical provider and patient
honesty is strengthened by the use of SDM. Patients are more likely to share personal
information needed to inform treatment options. Research supports that a trusting relationship
with a clinical provider can strengthen alliance and prevent crises or other serious negative
outcomes (Arnow & Steidtmann, 2014; Howgego et al, 2003). To improve partnerships, clinical
providers can offer options and have a conversation, even when yielding to the patient’s request
is not feasible. As part of this conversation, providers must consider there is a certain dignity in
risk-taking, even when not medically supported (i.e. getting off medication). Providers can state
the pros and cons of certain decisions, but the final decision is the patients, assuming decisional
capacity is intact. Although there is less of an emphasis of SDM in mental health care (Pollard,
2015; De las Cuevas et al, 2013; Drake et al, 2010; Hamann et al, 2006), the findings of this
study suggest the use of a SDM approach is more important in this filed compared to traditional
somatic care. Psychiatric care is dependent on the nature of communication and this is
instrumental in whether care is deemed effective. When you do not have a clearly superlative
treatment, often the case in psychiatry, the reliance on SDM becomes more important (Morant et
al, 2016). As mental health treatment increasingly reaches toward a recovery-oriented system of
care, Barry & Edgman-Levitan argue that SDM is the highest form of patient-centered care.

Implications for Research
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There is a need for more effectiveness studies on the influence of training in SDM practices for
both patients and providers. Patients may benefit from learning about the methodology of SDM
to level the playing field. That is, more explicitly explaining the concept, what it means, the
benefits and the responsibilities involved. Likewise, in the increasingly diversified field of
healthcare, practitioners enter their jobs with differing amounts of education on SDM practices.
The effect of attempts to improve providers’ knowledge on this practice and implementation of
SDM within the healthcare field remains insufficient (Legare et al, 2018). Implementation
science research on the uptake of SDM strategies into organizational culture and climate is
needed. Additionally, investigation of racial and ethnic differences in decision-making
preferences can better inform clinical providers on how to individualize communication on
decisional authority. While this study has too small a sample to draw conclusions on
demographic information, the tendency for white Hispanic females to cede their autonomy needs
further investigation. In somatic medicine, most interventional research on SDM has focused on
decision aids to help patients build their preferences or to facilitate any kind of patient
engagement (O’Connor et al, 2011) with far fewer attempts in the use of this strategy in mental
health (Drake et al, 2010). The use of decision aids was not endorsed in this study but may be
important in empowering patients to make more independent and informed choices.

While many important themes and implications for future work were found from this research,
several limitations are present. All interviews were performed in one clinic with individuals who
spoke English. Interviewing patients and providers in different areas and those who speak other
languages may have extended the variability of responses. Only one of 24 total participants were
African American limiting the generalizability of these findings. Additionally, the concept of
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SDM was new to several of the patient participants and it is possible that our explanations
influenced their answers.

In conclusion, shared decision making was viewed positively by all providers and most patients,
although there is a wide range of opinions in the amount of power either person should have in
medical decision making. Some patients are more likely to cede their control to the provider,
resulting in the need for providers to adapt their approach to presenting information and eliciting
patient engagement. Trust and honest communication is foundational to improved patient
outcome and shared decision making is a tool to foster necessary engagement.
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Table 2.1 Participant Characteristics

Age
Gender
Ethnicity

Patients (n = 15)
M = 41.2 (SD = xx)
4 m, 10 f, 1 nb
white Hispanic (8)
white non-Hispanic (6)
African American (1)

Providers (n = 9)
M = 48.9 (SD = 9.1)
4 m, 5 f
white Hispanic (4)
non-Hispanic white (5)
African American (0)
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Table 2.2. Exemplary Quotes from Six Themes
Differences in the Use of SDM
“Yeah, we’ll talk about it, and then he’ll tell me about other medications, and then we pretty much kind of make the
decision together.” patient
“Well, I was doing good and everything, but all of a sudden, I started getting itches, and I just started feeling weird
and stuff, so I was like, ‘Okay, it’s not for me. I don’t think this one’s working, doc.’ And he’s like, ‘Okay. We’ll try
something else.’” patient
“I’ve been tempted. Real tempted [to stop all medication]. But the doctor here also says ‘It’s your choice.’ And
that’s a real shared decision in saying he doesn’t think it’s a great idea. He really don’t…But, he still let’s me make
the final decision.” patient
“I’ve had a lot of really good luck with collaborative decision making in this office.” patient
“But he’s just very determined. If he decides something that’s what it is. He has a lot more power. There’s no
partnership.” patient
“The goal is for them [patients] to be equal partners without any power differential or hierarchy.” provider
“By discussing the available and data driven treatments with the advantages and disadvantages for each treatment, it
allows the client to be informed of their options for treatment and allows them the opportunity to give input on how
they want to be treated?” provider
Consideration of Past Experiences
“I was detained for, I felt for being honest… I told her exactly how I felt…and I ended up being detained and
hospitalized. And I’m like, Well, the hell with this. I’m not gonna talk to these people ever again.” patient
“It’s terrible. They don’t even care. They just give you these prescriptions, thank you, bye-bye.” patient
“I’ve been here a while and it’s not fun, changing from one doctor and starting over. And I don’t want to do that,
but I do want my doctor to understand me. I want to because the feeling of a panic attack is horrible. He [the doctor]
doesn’t listen.” patient
“It didn’t start off well. I was very angry. I was angry with the cops, I was angry with everybody and angry when I
came in here. I came into the clinic very angry and did not want to be here. It was a forced situation. patient
“A lot of them [patients] said we didn’t know this was something that we should do because for so long we were
told that we were unable to make decisions.” provider
“Hearing the patient’s point of view really opened my eyes to how they were disempowered and how all the control
was essentially put on someone else in their past.” provider
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“I’ve seen patients surprised and really engaged in thinking about stuff that they weren’t expecting to be thinking
about.” provider
“A lot of them shied away from having input and a lot of them said that’s not my place. I should never tell a doctor
what to do.” provider
“Learning SDM practices takes time and practice for those who were trained to be more paternalistic.” provider
Decisional Power Preferences
“I think it should be a mix of both…Because you know what’s best for yourself, and then, well, the doc knows
what’s best for you medically through her license. So I think it should be both. It’s a good thing. There’s a balance
there.” patient
“No – I don’t think so. I guess because of what did happen to me and that caused me to be here…I think it should
still be both because if it was more one-sided – I don’t know how that would work because that’s giving more power
to the other person over your life. I think it should still be discussed by both parties equally.” patient
“The doctor should have slightly more because he’s the book smart. He’s done all the education to be the doctor.”
patient
“…because I say of course he knows better than me. I’m gonna say this and that. Who am I? I’m just there, so I
come here for the help, you know. And that’s it.” patient
“We should have less than 50%, unless the patient is exhibiting problems with decisional capacity at that time.”
provider
“It may be something like the patient has 65%, doctor has maybe 25%, and then other has 10%, which could include
people like family members.” provider
Use of SDM in Psychiatry Versus Other Areas of Medicine
“It [SDM approach] helps a lot because I never talked about my past traumas before.” patient
“It helps build a trust and respect. I’m not like a paycheck or salary. I respect them [providers] more because they
show respect to me.” patient
“It [SDM] offered me an opportunity to assess where I was headed and choose if I wanted to return to the path that
I’d already set out for myself, or veer off on another course.” patient
“It [SDM] makes patients want to participate in the process and feel engaged in the process. So I think it probably
increased appointment adherence and prescribed treatments, which results in improved outcomes.” provider
“The prescriber has the opportunity to build trust with the patient through the SDM process. When the patient is
informed about their treatment options, they are more inclined to engage in treatment.” provider
Dignity and Disengagement
“…with regards to medication, there was one time when I introduced the idea of going off medication and he
[prescriber] was extremely opposed to the idea of me going off medication…I began experimenting with going off
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the medication on my own rather than doing so in an observed environment. So I stopped wanting to come in for
mental health treatment, which turned into its own snowball of bad feelings. And really hurt. Then when things
became a big problem for me, I wasn’t in an environment where I could be assisted, and so by the time that I
returned to that environment, it was an emergency situation.” patient
“The doctors that I had seen, she pretty much just made the decision for me, whenever I was saying I wasn’t feeling
good, or whatever, trying to decide what medication to take. She pretty much just made the decision. I don’t really
like that clinic and I didn’t go back.” patient
“You need to take me into consideration because I know my body.” patient
“Sometimes I wish that, whatever doctor that I’m at, I wish that they could just feel what I’m feeling for just a
minute so they could just have a little taste of what I go through.” patient
“I really deeply believe in the importance of patients feeling autonomous, feeling that they are the main person
guiding their life.” provider
External Forces Impacting SDM
“Yes, when symptoms, like impulsivity make me forget the long-term goal.” patient
“…there’s an ability for, kind of, a circumnavigation. Like if I’m starting to veer off course there’s a way of just
circumventing that. I probably wouldn’t be going back to school in January if she hadn’t done that [made the
decision].” patient
“Not in my experience. There is never a time when the doctor should have more say than the patient.” patient
“If somebody is talking about self-harm…in those moments the doctor needs to step in, in a much more directive
way.” provider
“For example, I’ll have patients come in and say, ‘I want to do this.’ And I’ll say, Well, I don’t completely y agree
with it, although there is no absolute contraindication. These are the risks associated with it. It’s important to me that
you accept the risks.” provider
“When there’s an absolute contraindication, then I say, ‘There’s an absolute contraindication to this and I won’t
prescribe it.’” provider
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OVERALL CONCLUSION
This study contributed to the limited published literature on SDM within the mental
health field. To our knowledge this is the first evaluation of the perceptions and preferences of
individuals with serious mental illness and their providers regarding SDM in a clinic serving a
population immediately following a psychiatric crisis or hospitalization. Race/ethnicity is an
important factor when using a SDM approach. African American individuals were more likely to
want to be active or collaborative contributors in the medical decision-making process likely
linked to a complex history of race in the medical profession. Many disparities are reported in
the area of mental health when comparing African Americans to whites, including higher levels
of incorrect diagnoses, underrepresentation in research, less access to treatment, more severe
symptom ratings, greater functional impairment once diagnosed, and significantly fewer African
Americans seeking treatment (Cosh et al, 2017; Cook et al, 2007; Parker & Satkoske, 2012;
Oluwoye et al, 2018). Furthermore, Eliacin et al (2016) reports African Americans are less
likely to be engaged in treatment and often perform more poorly on healthcare activities linked
to patient engagement, such as communicating effectively with providers and participating in
treatment decisions. To this end, active engagement and participation in mental health treatment
may represent an important component in addressing many of these inequalities.

In contrast to African Americans, Hispanic individuals were more likely to choose a
passive role in decision-making or cede their autonomy in decisional control. From a historical
perspective, Hispanic individuals tend to be respectful of authority and more likely to adhere to a
perceived power gradient, making them more likely to cede decision making to a medical
provider (Kemp & Rasbridge, 2004; Gudykunst, 2004). Research indicates Hispanics are more
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deferential to authority figures, depending on acculturation, and are less likely to engage in
mental health treatment than whites (Patel & Bakken, 2010). For these reasons, Añez et al
(2008) proposed the application of motivational interviewing principles to Latino cultural values
and emphasizes the need to promote a client-centered and culturally congruent therapeutic
environment to improve the connection to and participation of these individuals. Providers may
also work to improve their Hispanic patients’ self-efficacy in making sound medical decisions by
dividing tasks and offering feedback and reinforcement for each aspect of illness selfmanagement.

It is evident that baseline decision-making preferences need to be considered when
providing mental health care. Patients of all races/ethnicities need to be aided on how to engage
in the process of SDM and providers need to ensure they communicate the importance of active
and collaborative participation, even in situations that may be new for individuals in treatment.
This may involve recognizing the patient’s knowledge, allowing sufficient time for participation
or explaining the benefits of participating in treatment including improved health outcomes and
better quality of life (Vahdat et al, 2014). In line with the emerging paradigm of patient-centered
care, culturally appropriate decision making needs to be emphasized.

While race/ethnicity is an important consideration when using a shared decision-making
approach, other demographic, clinical and communication characteristics were not predictive of
control preference style in this context. It may be other factors are more important in determining
the extent to which someone wants to contribute in psychiatric decision making. The participants
in this study had in common a recent acute psychiatric hospitalization or crisis. Perhaps given
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this often traumatic and stressful event, other characteristics, such as age, gender and symptom
acuity become less important as related to shared decision-making preferences. Other possible
explanations not explored in this study include previous experiences in the mental health system,
including hospitalizations and personality traits.

The results of this study suggest that patients and providers value the SDM approach,
understand its application, and believe it is related to better clinical outcomes. Several important
topics are evident and can inform future clinical care and research in this field. Regarding
implications for clinical practice, the study supports the need to ensure that SDM is a routine
practice in psychiatric care. Patients and providers identified potential serious consequences
including, disengagement and abruptly terminating treatment, when patients do not participate in
decisions and do not feel heard. Studies of SDM connect increased patient involvement to
improved treatment adherence and quality of life, while lack of patient involvement is related to
lower adherence to treatment, patient satisfaction, and overall health outcomes (Sepucha &
Mulley, 2009). The reports in this study that SDM improved show rates and reduced calls in
between appointments is important to patients, providers and the agencies for which they work.
Research continually demonstrates no shows increase overall healthcare costs and reduce the
gains made from treatment (Kheirhah et al, 2016, Berg et al, 2013).

Both patients and providers in this study assert that trust in the clinical provider and
patient honesty is strengthened by the use of SDM. Patients are more likely to share personal
information needed to inform treatment options. Research supports that a trusting relationship
with a clinical provider can strengthen alliance and prevent crises or other serious negative
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outcomes (Arnow & Steidtmann, 2014; Howgego et al, 2003). To improve partnerships, clinical
providers can offer options and have a conversation, even when yielding to the patient’s request
is not feasible. As part of this conversation, providers must consider there is a certain dignity in
risk-taking, even when not medically supported (i.e. getting off medication). Although there is
less of an emphasis of SDM in mental health care (Pollard, 2015; De las Cuevas et al, 2013;
Drake et al, 2010; Hamann et al, 2006), the findings of this study suggest the use of a SDM
approach is more important in this field compared to traditional somatic care. Psychiatric care is
dependent on the nature of communication and this is instrumental in whether care is deemed
effective. When you do not have a clearly superlative treatment, often the case in psychiatry, the
reliance on SDM becomes more important (Morant et al, 2016).

Regarding implications for future research, there is a need for more effectiveness studies
on the influence of training in SDM practices for both patients and providers. Patients may
benefit from providers more explicitly explaining the concept of SDM, what it means, and the
benefits and the responsibilities involved. Likewise, in the increasingly diversified field of
healthcare, practitioners enter their jobs with differing amounts of education on SDM practices.
The effect of attempts to improve providers’ knowledge on this practice and implementation of
SDM within the healthcare field remains insufficient (Legare et al, 2018). Implementation
science research on the uptake of SDM strategies into organizational culture and climate is
needed. Additionally, investigation of racial and ethnic differences in decision-making
preferences can better inform clinical providers on how to individualize communication on
decisional authority.
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There are several limitations to this study that should be noted. Multiple tests of statistical
significance were utilized in the quantitative analyses and may have increased the likelihood that
the relationship between race/ethnicity and control preference group was due to chance. The
cross-sectional nature of this study did not allow for examination of difference in SDM styles
over time and a relatively smaller percentage of African American study participants make it
difficult to generalize from these results. The control preference groups were determined by one
self-reported assessment. While the Control Preferences Scale is a validated instrument, it is
possible that more sensitive scales or use of more than one scale is needed. Additionally, all
interviews were performed in one clinic with individuals who spoke English. Interviewing
patients and providers in different geographic areas and those who speak other languages may
have extended the variability of responses.

Despite the limitations described above, the study highlighted that SDM preferences are
different across individuals in this treatment setting. These preferences need to be considered in
approaching SDM education for patients and providers and in creation of culturally informed
decision aids and manuals. The concept of SDM is not a new one, however, we are experiencing
a paradigm shift with more emphasis in self-directed care in the mental health system. Both
providers and patients want to share in medical decision making, but neither may be completely
certain how to appropriately engage in collaborative exchange. This may be especially true for
providers and their patients who have recently been discharged from an inpatient setting. Using
culturally congruent decision aids and increasing patient activation and self-efficacy in making
medical decisions may be viable methods of engaging individuals in care, thereby increasing
collaborative decision-making. SDM has been demonstrated to improve outcomes for people
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across many areas of mental and physical health and must be implemented with thoughtful
consideration of patients to realize its full potential.
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Appendix A. Control Preferences Scale - Cards

I PREFER TO MAKE THE FINAL SELECTION
ABOUT WHICH TREATMENT I WILL RECEIVE.

I PREFER TO MAKE THE FINAL SELECTION
OF MY TREATMENT AFTER SERIOUSLY
CONSIDERING MY DOCTOR’S OPINION.

I PREFER THAT MY DOCTOR AND I
SHARE RESPONSIBILITY FOR
DECIDING WHICH TREATMENT IS
BEST FOR ME.
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I PREFER THAT MY DOCTOR MAKES THE
FINAL DECISION ABOUT WHICH
TREATMENT WILL BE USED, BUT
SERIOUSLY CONSIDERS MY OPINION.

I PREFER TO LEAVE ALL DECISIONS REGARDING
MY TREATMENT TO MY DOCTOR.
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Appendix B: Control Preference Scale Score Sheet
To score the completed scale, use the top 2 preferred cards to determine which category the
patient falls into.
Please circle the appropriate number for the top 2 cards:
1 – Active-Active (card order AB or BA) – enter 1 in the data file
2 – Active-Collaborative (card order BC) – enter 2 in the data file
3 – Collaborative-Active (card order CB) – enter 3 in the data file
4 – Collaborative-Passive (card order CD) – enter 4 in the data file
5 – Passive-Collaborative (card order DC) – enter 5 in the data file
6 – Passive-Passive (card order DE or ED) – enter 6 in the data file
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Appendix C: Matched Pair Instrument (Provider)
Using your opinion of today’s appointment, please rate each item using the 5-point scale provided.
Circle your response.
Not at
all true
1. Greeted the patient in a way
that made them feel
comfortable.
2. Discussed patient’s reason(s)
for coming today.
3. Encouraged patient to express
their thoughts concerning any
health problems
4. Listened carefully to what they
had to say.
5. Understood what they had to
say.
6. If a physical exam or lab test
was needed, explained what
was done and why.
7. Discussed treatment options
with them.
8. Gave the patient as much
information as they wanted.
9. Checked with the patient to see
if the treatment plan was
acceptable.
10. Explained medications, if any,
including possible side-effects.
11. Encouraged the patient to ask
questions.
12. Responded to questions and
concerns.
13. Involved the patient in
decisions as much as he or she
wanted.
14. Discussed next steps including
any follow-up plans.
15. Checked to be sure the patient
understood everything.
16. Showed care and concern
about the patient as a person.

Slightly
true

Moderately
true

Mostly
true

Very
true

0

1

2

3

4

0

1

2

3

4

0

1

2

3

4

0

1

2

3

4

0

1

2

3

4

0

1

2

3

4

0

1

2

3

4

0

1

2

3

4

0

1

2

3

4

0

1

2

3

4

0

1

2

3

4

0

1

2

3

4

0

1

2

3

4

0

1

2

3

4

0

1

2

3

4

0

1

2

3

4
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17. Spent the right amount of time
with them.
18. Overall, I was satisfied with
this meeting today.

0

1

2

3

4

0

1

2

3

4
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Appendix D: Matched Pair Instrument (Consumer)
Using your opinion of today’s appointment, please rate each item using the 5-point scale provided. Circle
your response.

1. Greeted me in a way that made
me feel comfortable.
2. Discussed me reason(s) for
coming today.
3. Encouraged me to express my
thoughts concerning my health
problems
4. Listened carefully to what I
had to say.
5. Understood what I had to say.
6. If a physical exam or lab test
was needed, explained what
was done and why.
7. Discussed treatment options
with me.
8. Gave me as much information
as I wanted.
9. Checked to see if the treatment
plan was acceptable to me.
10. Explained medications, if any,
including possible side-effects.
11. Encouraged me to ask
questions.
12. Responded to my questions
and concerns.
13. Involved me in decisions as
much as I wanted.
14. Discussed next steps including
any follow-up plans.
15. Checked to be sure I
understood everything.
16. Showed care and concern
about me as a person.
17. Spent the right amount of time
with me.
18. Overall, I was satisfied with
my visit to the doctor today.

Not at
all true

Slightly
true

Moderately
true

Mostly
true

Very
true

0

1

2

3

4

0

1

2

3

4

0

1

2

3

4

0

1

2

3

4

0
0

1
1

2
2

3
3

4
4

0

1

2

3

4

0

1

2

3

4

0

1

2

3

4

0

1

2

3

4

0

1

2

3

4

0

1

2

3

4

0

1

2

3

4

0

1

2

3

4

0

1

2

3

4

0

1

2

3

4

0

1

2

3

4

0

1

2

3

4
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Appendix E: Brief Psychiatric Rating Scale (BPRS)
Instructions: This form consists of 24 symptom constructs, each to be rated on a 7-point scale
of severity ranging from “not present” to “extremely severe”. If a specific symptom is not rated,
mark “NA”, Not Assessed. Circle the number headed by the term that best describes the
patient’s present condition.
NA

1

7
Not Assessed Not Present
Extremely Severe

2

3

Very Mild

4

5

6

Mild Moderate Moderately Severe

Severe

Rate items 1-10 on the basis of patient’s self-report.
1.
2.
3.
4.
5.
6.
7.
8.
9.
10.

Somatic Concerns
Anxiety
Depression
Guilt
Hostility
Suspiciousness
Unusual Thought Content
Grandiosity
Hallucinations
Disorientation

NA
NA
NA
NA
NA
NA
NA
NA
NA
NA

1
1
1
1
1
1
1
1
1
1

2
2
2
2
2
2
2
2
2
2

3
3
3
3
3
3
3
3
3
3

4
4
4
4
4
4
4
4
4
4

5
5
5
5
5
5
5
5
5
5

6
6
6
6
6
6
6
6
6
6

7
7
7
7
7
7
7
7
7
7

4
4
4
4
4
4
4
4
4
4
4
4
4
4

5
5
5
5
5
5
5
5
5
5
5
5
5
5

6
6
6
6
6
6
6
6
6
6
6
6
6
6

7
7
7
7
7
7
7
7
7
7
7
7
7
7

Rate items 11-24 on the basis of observed behavior and speech
11.
12.
13.
14.
15.
16.
17.
18.
19.
20.
21.
22.
23.
24.

Conceptual Disorganization
Excitement
Motor Retardation
Blunted Affect
Tension
Mannerisms and Posturing
Uncooperativeness
Emotional Withdrawal
Suicidality
Self-neglect
Bizarre Behavior
Elevated Mood
Motor Hyperactivity
Distractibility

NA
NA
NA
NA
NA
NA
NA
NA
NA
NA
NA
NA
NA
NA

1
1
1
1
1
1
1
1
1
1
1
1
1
1
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2
2
2
2
2
2
2
2
2
2
2
2
2
2

3
3
3
3
3
3
3
3
3
3
3
3
3
3

Appendix F: BPRS Factors and Variables
Psychosis—includes Suspiciousness, Unusual Thought Content, Hallucinations, and Conceptual
Disorganization
Depression—includes Anxiety, Depression, and Guilt
Psychomotor Retardation—includes Motor Retardation, Blunted Affect, and Emotional
Withdrawal
Paranoia—includes Hostility, Suspiciousness, and Uncooperativeness
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Appendix G: Scale to Assess Unawareness of Mental Disorder (SUMD); (Abbreviated
Version)
1. Awareness of mental disorder.
In the most general terms, does the subject believe that s/he has a mental disorder, psychiatric
problem, or emotional difficulty, etc.?
0

Cannot be assessed

1

Aware: Subject clearly believes that s/he has a mental disorder

2
3

Somewhat: Is unsure about whether s/he has a mental disorder but can entertain the idea that s/he
might.

4
5

Unaware: Believes s/he does not have a mental disorder

2. Awareness of achieved effects of medication
What is the subject’s belief regarding the effects of medication? Does the subject believe that
medications have lessened the intensity or frequency of his/her symptoms (i.e. if applicable)?
0

Cannot be assessed

1

Aware: Subject clearly believes medications have lessened the intensity or frequency of his/her
symptoms.

2
3

Somewhat: Is unsure about whether medications have lessened the intensity or frequency of
his/her symptoms, but can entertain the idea

4
5

Unaware: Believes that medications have not lessened the intensity or frequency of his/her
symptoms.

3. Awareness of social consequences of mental disorder
What is the subject’s belief regarding the reason s/he has been admitted to the hospital, involuntarily
hospitalized, arrested, evicted, fired, injured, etc.?
0

Cannot be assessed

1

Aware: Subject clearly believes that the relevant social consequences are related to having a
mental disorder.

2
3

Somewhat: Is unsure about whether the relevant social consequences are related to having a
mental disorder.

4
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5

Unaware: Believes that the relevant social consequences have nothing to do with having a mental
disorder.
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Appendix H. Qualitative Interview Guide - Staff
Staff Interview Guide (Maples)
INTERVIEW GUIDE
Staff VERSION – Prescribers
Study Objective
OBJECTIVE:
The overall objective of this study is to
collect information from prescribers and
other involved staff the use of shared
decision making in the post-acute
psychiatric treatment setting (transitional
care clinic-TCC). The special focus of
this interview is to understand staff
experiences of shared decision making in
general and the Shared Decision Making
(SDM) intervention used at the
Transitional Care Clinic. In addition, we
would like to understand the impact of
SDM on the relationship between
patients and staff and the outcomes of the
patient.
Specific objectives are as follows:
1. Identify and document thoughts
about and experiences with
shared decision making in general
and using shared decision making
in patient encounters.
2. Clarify the importance of various
aspects of SDM from the staff
perspective including decision
tools, web materials, patient
videos and TAC-REVIEW.
3. Identify barriers and facilitators to
the use of SDM in the post-acute
psychiatric clinic setting.
4. Identify the impact of SDM on
outcomes.

Progression of Questions in Interview Guide

OVERALL FLOW:
Shared Decision Making: Open-ended
exploration of SDM in general
Specific questions about SDM
Basic Understanding
Experiences with SDM
Thoughts about responsibility and involvement
How much and what kind of information is
appropriate to provide?
Shared Decision Making intervention: Openended exploration of specific SDM thoughts and
impressions of the intervention and its impact
upon outcomes.
Usefulness of coaches
Impact on Timing and Length of psychiatric
appointments
Decision tools
Web sites
TAC-REVIEW
Barriers to using the intervention: What got in
the way of the processes of SDM or its
application?

Percieved limits to patient understanding
Percieved limits of competence
Limits of materials

Impact on process and outcomes
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INTERVIEWER INSTRUCTIONS
Your goal as the interviewer is to elicit information on the topics of interest without influencing
participant’s responses. To do this, begin each topic area with broad, open-ended questions, and
then ask more specific questions to clarify and elicit more detail regarding participant’s
responses.
Begin each topic area by posing questions broadly. Specific wording for the interviewer is
denoted in bold font. Follow with the more specific questions. It is not necessary to explicitly
ask each of the bulleted prompts within a topic area, but you should refer to the bullets to ensure
that each topic is addressed with sufficient coverage, rather than focusing on just one or two
narrow areas.
INTERVIEW GUIDE
TO BEGIN:
1. Introduce yourself and your association with the study.
2. Explain purpose of the interview.
3. Thank participants for their willingness to participate.
4. Assure the participant of confidentiality, including that this study will not impact
employment at TCC, and that neither other the TCC providers nor the SDM coach will
learn their answers.
5. Let them know the general process of how it will proceed.

The purpose of this interview:
This interview will take approximately 30-45 minutes. I will ask you a variety of questions
to help us better understand your experiences with shared decision making in general and
how this process works with patients. I will ask about your overall impressions, how SDM
impacts the timing and length of encounters, how the specific strategies used impact the
visit, and what works or does not work for you in terms of helping the patient understand
their options and communicating decisions. I will also ask your opinions about how the use
of SDM impacts patient outcomes.
How this interview will work:
I will start by asking more general questions then become more specific. I am interested in
what you have to say about your experiences, so please respond with whatever is on your
mind.
I want to remind you this interview is being recorded. I will not use your name from the
point that I turn on the recorder, and I will ask you to try and not use your name or the
names of specific patients or staff members in any of your responses. This will help keep
the interview anonymous.
I will use the recording only to remind me of the important things you said so we can use
your input. The recordings will be transcribed, and then put together with transcripts from
everyone else taking part in these interviews. All recordings will be deleted after they are
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transcribed. You will not be individually identified in any of the reports that result from
these interviews. I ask you for your honest opinion during this interview.
Do you have any questions or concerns before we begin?
INTERVIEW ITEMS

I.

FIRST DISCUSSION ITEM

Purpose: Initial, broad item to get participant to begin thinking about their SDM experiences,
what it entails, about their role in the process, and the information needed to make it work.
To start, I’d like you to think about shared decision-making in encounters with patients,
what it means and what you think about this approach to patient care.
1.
2.
3.
4.

How do you understand shared decision making?
In general, what do you think of the shared decision making approach?
Do you ever explain shared decision making to patients? If yes, how?
How much responsibility do you think you and other doctors should have in
decisions about patient’s mental health treatment?
5. Are there certain times when you want a lot of patient input into decision making?
(Some examples)
6. Are there certain times when you feel you want to be the primary decision maker
about the patient’s psychiatric treatment? (Some examples)
II.

SECOND DISCUSSION ITEM

Purpose: This item is designed to get participants to begin thinking about the SDM training and
use of the coach for patients at TCC specifically, what they thought and felt about it.
Now I’d like you to think about your experiences with SDM training and with SDM
coaching specifically at the Transitional Care Clinic.
1. What did you learn in the training? Was this new information?
2. What are some things you like or did not like about the patients participating in
shared decision making coaching?
3. What information do you think is needed from the SDM coach to help the patient
improve their visit with you?
4. How do you think SDM coaching impacts patient preparedness for visits with you?
III.

THIRD DISCUSSION ITEM

Purpose: The purpose of this item is to get the participant discussing any barriers or facilitators
they saw or experienced in the use of SDM in their clinic.
At this point I’d like you to think about things that might make it easy or difficult for you
to participate in a shared decision making approach to care at the Transitional Care Clinic.
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(These can be mirror images of the questions above and may be unnecessary if they have already
discussed.)
1. What kind of problems do you have in using SDM?
2. What are the difficulties in patients understanding SDM concepts?
3. What are the difficulties in patients taking more responsibility in making medical
decisions?
4. What is most helpful about the SDM approach?
5. What is least helpful?
6. How did you feel about the length of sessions with patients when using the SDM
model of care? (Did they get longer or take additional effort or resources due to
using SDM?)
7. Tell me about the costs of using an SDM approach. Do they outweigh the benefits?
(Why?)
8. What kinds of characteristics make it easier or more difficult for patients to engage
in SDM?
9. Thinking specifically about the use of SDM at the TCC, how do you feel about how
easy or difficult it was to fit this model into your treatment practices? (Why?)
10. Explain the benefits you personally receive in your work from using SDM, if any.
11. There is a movement to integrated models of healthcare. How do you feel SDM fits
within this public health priority?
12. Are there any other problems or benefits in using SDM we have not yet talked
about?
IV.

FOURTH DISCUSSION ITEM

Purpose: More specific focus on how SDM changed their participation in sessions with the
patient.
Now let’s get a little more focused and talk about how much and in what ways SDM
changed the way you interact with patients and vice versa. (These can be mirror images of
the questions above and may not be unnecessary if they have already discussed.)
1. Think of times you treated patients similar to those at the TCC prior to learning
shared decision making. What differences do you find in your treatment now?
2. What is different about your communication behavior with patients when using
SDM?
3. In what way does SDM impact the way you discuss a specific medication or
treatment with patients?
4. How do you think knowing SDM impacts how seriously you take patients’ input
about medical decisions?
5. What changes have you seen in patient’s communication to you as a result of
adopting SDM?
6. In using SDM, do you believe the patient feels like an equal partner in decisions
about their treatment? (Explain)
V.

FIFTH DISCUSSION ITEM
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Purpose: To gather information about how SDM impacted your outcomes
Think about how SDM impacts patient outcomes.
1. In what way do you believe SDM may help or hurt your patient’s recovery?
2. In what way do you believe SDM may help or hurt your patient’s engagement in
treatment?
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Appendix H2. Qualitative Interview Guide - Staff
Staff Interview Guide (Maples)
INTERVIEW GUIDE
Staff Version – Other Clinic Personnel
Study Objective
OBJECTIVE:
The overall objective of this study is to
collect information from prescribers and
other involved staff the use of shared
decision-making in the post-acute
psychiatric treatment setting (transitional
care clinic-TCC). The special focus of
this interview is to understand staff
experiences of shared decision making in
general and the Shared Decision Making
(SDM) intervention used at the
Transitional Care Clinic. In addition, we
would like to understand the impact of
SDM on the relationship between
patients and staff and the outcomes of the
patient.
Specific objectives are as follows:
5. Identify and document thoughts
about and experiences with
shared decision making in general
and using shared decision making
in patient encounters.
6. Clarify the importance of various
aspects of SDM from the staff
perspective including decision
tools, web materials, patient
videos and TAC-REVIEW.
7. Identify barriers and facilitators to
the use of SDM in the post-acute
psychiatric clinic setting.
8. Identify the impact of SDM on
outcomes.

Progression of Questions in Interview Guide

OVERALL FLOW:
Shared Decision Making: Open-ended
exploration of SDM in general
Specific questions about SDM
Basic Understanding
Experiences with SDM
Thoughts about responsibility and involvement
How much and what kind of information is
appropriate to provide?
Shared Decision Making intervention: Openended exploration of specific SDM thoughts and
impressions of the intervention and its impact
upon outcomes.
Usefulness of coaches
Impact on Timing and Length of psychiatric
appointments
Decision tools
Web sites
TAC-REVIEW
Barriers to using the intervention: What got in
the way of the processes of SDM or its
application?

Percieved limits to patient understanding
Percieved limits of competence
Limits of materials
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Impact on process and outcomes

INTERVIEWER INSTRUCTIONS
Your goal as the interviewer is to elicit information on the topics of interest without influencing
participant’s responses. To do this, begin each topic area with broad, open-ended questions, and
then ask more specific questions to clarify and elicit more detail regarding participant’s
responses.
Begin each topic area by posing questions broadly. Specific wording for the interviewer is
denoted in bold font. Follow with the more specific questions. It is not necessary to explicitly
ask each of the bulleted prompts within a topic area, but you should refer to the bullets to ensure
that each topic is addressed with sufficient coverage, rather than focusing on just one or two
narrow areas.
INTERVIEW GUIDE
TO BEGIN:
6. Introduce yourself and your association with the study.
7. Explain purpose of the interview.
8. Thank participants for their willingness to participate.
9. Assure the participant of confidentiality, including that this study will not impact
employment at TCC, and that neither other the TCC providers nor the SDM coach will
learn their answers.
10. Let them know the general process of how it will proceed.

The purpose of this interview:
This interview will take approximately 45-60 minutes. I will ask you a variety of questions
to help us better understand your experiences with shared decision making in general and
how this process works with patients. I will ask about your overall impressions, how SDM
impacts the timing and length of encounters, how the specific strategies used impact the
visit, and what works or does not work for you in terms of helping the patient understand
their options and communicating decisions. I will also ask your opinions about how the use
of SDM impacts patient outcomes.
How this interview will work:
I will ask general questions, and after each one there will be some time for you to respond.
We are interested in what you have to say about your experiences, so please respond with
whatever is on your mind.
I want to remind you this interview is being recorded. I will not use your name from the
point that I turn on the recorder, and I will ask you to try and not use your name or the
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names of specific patients or staff members in any of your responses. This will help keep
the interview anonymous.
I will use the recording only to remind me of the important things you said so we can use
your input. The recordings will be transcribed, and then put together with transcripts from
everyone else taking part in these interviews. All recordings will be deleted after they are
transcribed. You will not be individually identified in any of the reports that result from
these interviews. I ask you for your honest opinion during this interview.
Do you have any questions before we start?

INTERVIEW ITEMS
VI.

FIRST DISCUSSION ITEM

Purpose: Initial, broad item to get participant to begin thinking about their SDM experiences,
what it entails, about their role in the process, and the information needed to make it work.
To start, I’d like you to think about shared decision-making in encounters with patients,
what it means and what you think about this approach to patient care.
7. How do you understand shared-decision making?
8. How do you feel about someone helping the patient prepare for visits with their
doctor and other members of the treatment team?
9. In general, what do you think of the shared decision-making approach?
10. How do you explain shared decision making to patients?
11. How much responsibility do you think doctors should have in decisions about their
patient’s mental health care?
12. What are some examples of when you think the doctor should be the primary
decision maker?
13. What are some examples of when you think the patient should be the primary
decision maker?
VII.

SECOND DISCUSSION ITEM

Purpose: This item is designed to get participants to begin thinking about the SDM training and
use of the coach for patients at TCC specifically, what they thought and felt about it.
Now I’d like you to think about your experiences with SDM training and with the SDM
coach at the Transitional Care Clinic.
5. What did you learn in the training? Was this new information?
6. What are some things you like or do not like about having patients participate in the
shared decision making meetings with a coach?
7. What information do you think is needed from an SDM coach to help the patient
improve their visit with the doctor?
8. How do you think SDM coaching impacts patient preparedness for doctor’s visits?
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VIII.

THIRD DISCUSSION ITEM

Purpose: The purpose of this item is to get the participant discussing any barriers or facilitators
they saw or experienced in the use of SDM in their clinic.
At this point I’d like you to think about things that might make it easy or difficult for you
to participate in an SDM approach to care. (These can be mirror images of the questions
above and may be unnecessary if they have already discussed.)
13. What kind of problems do you have using SDM?
14. What are the difficulties in patients understanding SDM concepts?
15. What are the difficulties in patients taking more responsibility in making medical
decisions?
16. What is most helpful about the SDM approach?
17. What is least helpful?
18. How do you feel about addition of and length of the sessions for SDM coaching?
19. Tell me about the costs of using an SDM approach. Do they outweigh the benefits?
(Why?)
20. What kinds of characteristics make it easier or more difficult for patients to engage
in SDM?
21. Thinking specifically about the use of SDM at the TCC, how do you feel about how
easy or difficult it was to fit this model into clinic practices? (Why?)
22. Explain the benefits you personally receive in your work from using SDM, if any.
23. There is a movement to integrated models of healthcare. How do you feel SDM fits
within this public health priority?
24. Are there any other problems or benefits in using SDM that we have not yet talked
about?
IX.

FOURTH DISCUSSION ITEM

Purpose: More specific focus on how SDM changed their participation in sessions with the
patient.
Now let’s get a little more focused and talk about how much and in what ways SDM
changed the way you interact with patients, and how they interact with you or other clinic
staff. (These can be mirror images of the questions above and may be unnecessary if they have
already discussed.)
7. In what ways do you think SDM coaching changes the way patients try to work with
their doctor in decision making?
8. What is different about your communication behavior with patients when using
SDM?
9. How do you think knowing SDM impacts how seriously you take patients’ thoughts
and concerns?
10. What changes have you seen in patient’s communication to you or other clinic staff
as a result of adopting SDM?
11. Do you think the patient feels like an equal partner in decisions about their
treatment? (Explain)
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X.

FIFTH DISCUSSION ITEM

Purpose: To gather information about how SDM impacted your outcomes
Think about how SDM impacts patient outcomes.
3. In what way do you believe SDM may help or hurt patient recovery?
4. In what way do you believe SDM may help or hurt patient engagement in
treatment?
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Appendix I: Qualitative Interview Questions – Patient Version
Patient Interview Guide (Maples)
INTERVIEW GUIDE
PATIENT VERSION
Study Objective
OBJECTIVE:
The overall objective of this study is to
collect information from patients about
their preferences in sharing decisions
about their post-acute psychiatric
treatment. The special focus of this
interview is to understand patient desires
and experiences of shared decision
making in general and the Shared
Decision Making (SDM) intervention
used at the Transitional Care Clinic
including the prescriber, SDM coach,
specific techniques and available
resources. In addition, we would like to
understand the impact of SDM on the
patient’s treatment and outcomes.
Specific objectives are as follows:
9. Identify and document patient
thoughts about and experiences
with shared decision making in
general and responses to the
shared decision making
intervention.
10. Clarify the importance of various
aspects of SDM treatment
including decision tools, web
materials, patient videos and
TAC-REVIEW.
11. Identify barriers and facilitators to
the use of SDM in the post-acute
psychiatric clinic setting.
12. Identify the impact of SDM on
outcomes.

Progression of Questions in Interview Guide

OVERALL FLOW:
Shared Decision Making: Open-ended
exploration of SDM in general
Specific questions about SDM
Basic Understanding
Experiences with SDM
Thoughts about responsibility and involvement
How much and what kind of information might
be needed?
Shared Decision Making intervention: Openended exploration of specific SDM thoughts and
impressions of the intervention and its impact
upon outcomes.
Usefulness of coaches
Timing and Length
Decision tools
Web sites
TAC-REVIEW
Barriers to using the intervention: What got in
the way of the processes of SDM or its
application?
Limits of information
Percieved limits to understanding
Time and timing
Limits of practitioners
Limits of materials
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INTERVIEWER INSTRUCTIONS
Your goal as the interviewer is to elicit information on the topics of interest without influencing
participant’s responses. To do this, begin each topic area with broad, open-ended questions, and
then ask more specific questions to clarify and elicit more detail regarding participant’s
responses.
Begin each topic area by posing questions broadly. Specific wording for the interviewer is
denoted in bold font. Follow with the more specific questions. It is not necessary to explicitly
ask each of the bulleted prompts within a topic area, but you should refer to the bullets to ensure
that each topic is addressed with sufficient coverage, rather than focusing on just one or two
narrow areas. Recall that not all information appearing in
INTERVIEW GUIDE
TO BEGIN:
11. Introduce yourself and your association with the study.
12. Explain purpose of the interview.
13. Thank participants for their willingness to participate.
14. Assure the participant of confidentiality, including that this study is not related to the
treatment they will receive at TCC, and that neither the TCC providers nor SDM coach
will learn their answers.
15. Let them know the general process of how it will proceed.

The purpose of this interview:
This interview will take approximately 30-45 minutes. I will ask you a variety of questions
that will help us to better understand your experiences with shared decision making in
general, how this process goes with your shared decision making coach and prescriber. I
will ask about your overall impressions, how the timing and length of SDM sessions work,
how the specific things the SDM coach did or the tools she used impacted you, what does
and does not work for you in terms of helping you understand your options and
communicate your decisions to the treatment team. I will also ask how the SDM sessions
impacted your outcomes in treatment.
How this interview will work:
I will be asking general questions, and after each one there will be some time for you to
respond. We are interested in what you have to say about your experiences, so please
respond with whatever is on your mind.
I want to remind you that this interview is being recorded. I will try to not use your name
from the point that I turn on the recorder, and I will ask you to try and not use your name
or the names of friends or family in any of your responses. This will help keep the interview
anonymous.
140

I will be using the recording only to remind me of the important things you said so we can
use your input. The recordings will be transcribed, and then put together with transcripts
from everyone else taking part in these interviews. All recordings will be deleted after they
are transcribed. You won’t be able to be individually identified in any of the reports that
result from these interviews.
Do you have any questions before we start?
INTERVIEW ITEMS

XI.

FIRST DISCUSSION ITEM

Purpose: Initial, broad item to get participant to begin thinking about their SDM experiences,
what it entails, about their role in the process, and the information needed to make it work.
To start, I’d like you to think about shared decision-making when making decisions about
your psychiatric treatment, what it means and what you think about it.
•
•
•
•
•
•
•
•

How do you understand shared decision making?
How do you feel about someone helping you to prepare for visits with your doctor?
In general, what do you think of the shared decision making approach?
Are there certain decisions where you want input from others before you make
them? (Some examples)
Are there certain decisions that you want a doctor to make? (Some examples)
How much responsibility do you want to have in decisions about your mental health
care?
What information do you think is needed from your coach and doctor to help you
make good decisions?
How do you think the information should be presented?

XII.

SECOND DISCUSSION ITEM

Purpose: This item is designed to get participants to begin thinking about their SDM experience
at TCC specifically, what they thought and felt about it.
Now I’d like you to think about your experiences with the SDM coach at the TCC.
What are some things that you liked or did not like about being in the shared decision
making meetings with your coach?
You may have experienced different things in SDM or been exposed to different tools
depending on your needs. So you may not have experience with many of the things I will
list. But if you did use them please let me know what you thought about them, positive or
negative. (Were they helpful, not useful…)
•

Specific tools (handouts)
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•
•
•

Websites
Patient videos
TAC-REVIEW process

XIII.

THIRD DISCUSSION ITEM

Purpose: The purpose of this item is to get the participant discussing any barriers or facilitators
they saw or experienced in the use of SDM in their clinic.
At this point I’d like you to think about things that might have made it difficult for you to
participate in SDM and things that helped to move the process along. (These can be mirror
images of the questions above and may be unnecessary if they have already discussed.)
•
•
•
•
•
•
•
•

What kind of problems did you have in participating in SDM?
What were the difficulties in understanding shared-decision making?
What kind of problems or gaps were there in the information you received from the
coach or prescriber?
What was most helpful about shared decision making?
What was least helpful?
How did you feel about the length of the sessions? How did you feel about how easy
or difficult it was to fit the SDM sessions into your visits with your doctor?
What kinds of things did your doctor do that may have made it harder for you to
engage in decisions about your treatment?
Were there any other problems in using SDM that we have not yet talked about?

XIV. FOURTH DISCUSSION ITEM
Purpose: More specific focus on how SDM changed their participation in sessions with the
prescriber.
Now let’s get a little more focused and talk about how much and in what ways SDM
changed the way you spoke with your doctor. (These can be mirror images of the questions
above and may be unnecessary if they have already discussed.)
Think of times you met with a doctor before shared decision-making? What differences did
you find in your treatment?
• In what ways has your participation in SDM coaching changed the way you work
with your doctor?
• In what way did you notice differences in your behavior?
• In what way did you notice differences in your feelings?
• In what way did notice differences in how your sessions went compared with other
medical office visits?
• In what way did you notice differences in how prepared you thought you were for
the visit with your doctor?
• How do you think SDM impacted how seriously your thoughts and concerns were
taken by the provider?
• In what way did you feel more or less comfortable voicing your opinion?
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•
•

In what way did you feel more or less confident about the choices you made?
Did you feel more like an equal partner in your decisions? (Explain)

XV.

FIFTH DISCUSSION ITEM

Purpose: To gather information about how SDM impacted your outcomes
Think about how SDM impacted your outcomes.
•
•

In what way did SDM help or hurt your recovery?
In what way did SDM help or hurt your chances of continuing mental health
treatment?
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